Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1C (migalastat)1件: Migalastat2件: Migalastat hydrochloride ,
Migalastat 💬 		1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬1件: 19 💬
2C-028380----1件: 106 💬
3C-1-esterase----1件: 65 💬
4C-11 ER176----3件: 6, 17, 127 💬
5C-11 ER176 Radiotracer----1件: 13 💬
6C-11 PiB----3件: 6, 17, 127 💬
7C-82 Topical Gel, 1%----1件: 51 💬
8C-kit+ cells----1件: 211 💬
9C-Trelin OD Tab(5mg Taltirelin Hydrate)1件: Taltirelin---1件: 18 💬
10C-type natriuretic peptide conjugated to a multi-arm polyethylene glycol carrier molecule through a cleavable linker1件: Polyethylene glycol3件: Polyethylene glycol 3350 ,
Macrogol 4000 ,
Macrogol 6000 💬 		--1件: 276 💬
11C-TYPE NATRIURETIC PEPTIDE CONJUGATED TO MULTI-ARM POLYETHYLENE GLYCOL CARRIER THROUGH A CLEAVABLE LINKER1件: Polyethylene glycol3件: Polyethylene glycol 3350 ,
Macrogol 4000 ,
Macrogol 6000 💬 		--1件: 276 💬
12C. albicans----1件: 46 💬
13C. cicadae----1件: 2 💬
14C01CA04 - Dopamina----1件: 299 💬
15C01EB19----1件: 65 💬
16C03C----1件: 57 💬
17C03DB01----1件: 222 💬
18C03XA01----2件: 67, 72 💬
19C07AB07----1件: 86 💬
20C09----1件: 66 💬
21C1 ESTERASE INHIBITOR----1件: 65 💬
22C1 ESTERASE INHIBITOR (HUMAN)----1件: 65 💬
23C1 esterase inhibitor [human]----1件: 65 💬
24C1 esterase inhibitor [human] (C1INH-nf)----1件: 65 💬
25C1 esterase inhibitor [human] liquid----1件: 65 💬
26C1 esterase inhibitor concentrate----1件: 65 💬
27C1 esterase inhibitor concentrate, human, pasteurized----1件: 65 💬
28C1 Esterase Inhibitor Human----1件: 65 💬
29C1 esterase inhibitor liquid for injection----1件: 65 💬
30C1 inhibitor (human) [C1 INH]----1件: 65 💬
31C1 inhibitor concentrate----1件: 65 💬
32C1-Esterase Inhibitor----1件: 65 💬
33C1-esterase inhibitor (Cinryze)----1件: 13 💬
34C1-esterase inhibitor - single intravenous dose----1件: 65 💬
35C1-esterase inhibitor - subcutaneous high dose----1件: 65 💬
36C1-esterase inhibitor - subcutaneous low dose----1件: 65 💬
37C1-esterase inhibitor - subcutaneous medium dose----1件: 65 💬
38C1-esterase inhibitor [recombinant] (C1-INH-R)----1件: 65 💬
39C1-Esterase-Inhibitor----1件: 65 💬
40C105----1件: 13 💬
41C106 solution----1件: 85 💬
42C10AA05----1件: 46 💬
43C10AB02----1件: 94 💬
44C11 Pittsburgh Compound B1件: Pittsburgh Compound B---1件: 13 💬
45C11-methionine1件: Methionine1件: Methionine 💬 --1件: 84 💬
46C11-SY08----2件: 6, 17 💬
47C21----2件: 51, 85 💬
48C225----2件: 51, 86 💬
49C2L-OCT-01 PR----1件: 77 💬
50C2L-OCT-01 PR , 10mg----1件: 77 💬
51C2L-OCT-01 PR , 20mg----1件: 77 💬
52C2L-OCT-01 PR , 30mg----1件: 77 💬
53C2L-OCT-01 PR 30 mg----1件: 77 💬
54C2L-OCT-01 PR, 10 or 20 mg----1件: 77 💬
55C2L-OCT-01 PR, 20 mg----1件: 77 💬
56C2L-OCT-01 PR, 30 mg----1件: 77 💬
57C3261件: C326---1件: 96 💬
58C326, IL-6 Inhibitory Avimer protein1件: C326---1件: 96 💬
59C5 inh MAb, SKY59, RO/CH7092230----2件: 62, 109 💬
60C5 Inhibitor----1件: 62 💬
61CA----1件: 234 💬
62CA2----1件: 271 💬
63CABA-201----5件: 11, 13, 35, 49, 51 💬
64CABA-201 following preconditioning with fludarabine and cyclophosphamide2件: Cyclophosphamide,
Fludarabine		4件: Cyclophosphamide ,
Fludarabine phosphate ,
Cyclophosphamide ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 50 💬
65Cabaletta----1件: 113 💬
66Cabaletta for IV infusion once weekly during 24 weeks----1件: 18 💬
67Cabaser----2件: 6, 77 💬
68Cabaseril----1件: 6 💬
69Cabaseril, 1,0 mg Tablette----1件: 6 💬
70Cabaseril, 2,0 mg Tablette----1件: 6 💬
71Cabergolin----2件: 74, 77 💬
72Cabergolin Teva----1件: 74 💬
73CABERGOLINA1件: Cabergoline1件: Cabergoline 💬 2件: DRD2,
PRL 💬 		14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬2件: 6, 75 💬
74Cabergoline1件: Cabergoline1件: Cabergoline 💬 2件: DRD2,
PRL 💬 		14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬4件: 6, 74, 75, 77 💬
75Cabergoline (Dopamine Agonist)2件: Cabergoline,
Dopamine		3件: Dopamine hydrochloride ,
Cabergoline ,
Dopamine 💬 		6件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5,
PRL 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 74 💬
76Cabergoline 1.5-2 mg/week).orally daily for 1 month plus health education1件: Cabergoline1件: Cabergoline 💬 2件: DRD2,
PRL 💬 		14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 74 💬
77Cabergoline 1.5-2 mg/week).orally daily for 1 month without health education1件: Cabergoline1件: Cabergoline 💬 2件: DRD2,
PRL 💬 		14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 74 💬
78Cabergoline tablets1件: Cabergoline1件: Cabergoline 💬 2件: DRD2,
PRL 💬 		14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 74 💬
79Cabergoline tablets reference formulation1件: Cabergoline1件: Cabergoline 💬 2件: DRD2,
PRL 💬 		14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 74 💬
80Cabergoline tablets test formulation1件: Cabergoline1件: Cabergoline 💬 2件: DRD2,
PRL 💬 		14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 74 💬
81CABERGOLINE TEVA1件: Cabergoline1件: Cabergoline 💬 2件: DRD2,
PRL 💬 		14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 75 💬
82CABLIVI----1件: 64 💬
83Cablivi®----1件: 64 💬
84Cablivi®Product Name: Cablivi®Product Code: ALX0081Pharmaceutical Form: Powder and solvent for solution for injectionINN or Proposed INN: CaplacizumabCAS Number: 915810-67-2Current Sponsor code: ALX0081Other descriptive name: Nanobody directed towards the human A1 domain of von Willebrand factorConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 12.5-Trade Name: Cablivi®Product Name: Cablivi®Product Code: ALX0081Pharmaceutical Form: Powder and solvent for solution for injectionINN or Proposed INN: CaplacizumabCAS Number: 915810-67-2Current Sponsor code: ALX0081Other descriptive name: Nanobody directed towards the human A1 domain of von Willebrand factorConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 12.5-----1件: 64 💬
85Cabozantinib1件: Cabozantinib2件: Cabozantinib ,
Cabozantinib s-malate 💬 		3件: AXL,
KDR,
MET 💬 		28件: Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Efferocytosis, Epithelial cell signaling in Helicobacter pylori infection, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, Hepatocellular carcinoma, IgSF CAM signaling, Integrin signaling, MAPK signaling pathway, Malaria, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Renal cell carcinoma, Transcriptional misregulation in cancer, VEGF signaling pathway 💬9件: 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
86Cabozantinib Oral Tablet1件: Cabozantinib2件: Cabozantinib ,
Cabozantinib s-malate 💬 		3件: AXL,
KDR,
MET 💬 		28件: Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Efferocytosis, Epithelial cell signaling in Helicobacter pylori infection, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, Hepatocellular carcinoma, IgSF CAM signaling, Integrin signaling, MAPK signaling pathway, Malaria, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Renal cell carcinoma, Transcriptional misregulation in cancer, VEGF signaling pathway 💬1件: 34 💬
87CACIPLIQ20----1件: 36 💬
88CACIT D3 effervescent granules, 500 mg/440 IU----1件: 97 💬
89CAD-1883----1件: 18 💬
90CADD-Legacy ambulatory infusion pump----1件: 6 💬
91CADD-Legacy® 1400 ambulatory infusion pump----1件: 6 💬
92CAEL-101----1件: 28 💬
93Caffeic acid----1件: 63 💬
94Caffeic acid tablets----1件: 63 💬
95Caffeine1件: Caffeine2件: Caffeine ,
Caffeine citrate 💬 		11件: ADORA1,
ADORA2A,
PDE1B,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE5A 💬 		22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬8件: 2, 6, 13, 21, 46, 96, 97, 265 💬
96Caffeine 100 mg1件: Caffeine2件: Caffeine ,
Caffeine citrate 💬 		11件: ADORA1,
ADORA2A,
PDE1B,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE5A 💬 		22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 96, 97 💬
97Caffeine 100-200 mg BID1件: Caffeine2件: Caffeine ,
Caffeine citrate 💬 		11件: ADORA1,
ADORA2A,
PDE1B,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE5A 💬 		22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
98Caffeine alkaloid1件: Caffeine2件: Caffeine ,
Caffeine citrate 💬 		11件: ADORA1,
ADORA2A,
PDE1B,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE5A 💬 		22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
99CAL101----1件: 85 💬
100Calcichew D3----1件: 274 💬
101Calcichew D3 Forte----1件: 113 💬
102Calcichew tablets----1件: 274 💬
103Calcifediol1件: Calcifediol1件: Calcifediol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬2件: 86, 113 💬
104Calcifediol Oral Capsule1件: Calcifediol1件: Calcifediol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 86 💬
105Calcineurin Inhibitors----1件: 50 💬
106Calcineurin inhibitors maintenance----1件: 67 💬
107CALCIO CARBONATO/COLECALCIFEROLO1件: Calcium---1件: 274 💬
108CALCIO FOLINATO DC.IT1件: Calcium---1件: 13 💬
109Calcipotriene----1件: 51 💬
110CALCIPOTRIOL1件: Calcipotriol2件: Calcipotriene ,
Calcipotriol hydrate 💬 		1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 36 💬
111Calcitonin----1件: 225 💬
112CALCITONIN (SALMON)----1件: 225 💬
113Calcitonin nasal spray (salmon)----2件: 96, 97 💬
114Calcitriol1件: Calcitriol1件: Calcitriol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬11件: 18, 37, 46, 49, 66, 96, 158, 223, 235, 238, 326 💬
115Calcitriol & Calcium2件: Calcitriol,
Calcium		1件: Calcitriol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 235 💬
116Calcium1件: Calcium---39件: 2, 3, 6, 13, 15, 19, 46, 48, 49, 51, 53, 56, 62, 67, 68, 71, 74, 75, 79, 84, 90, 93, 94, 95, 96, 97, 156, 186, 214, 215, 222, 224, 235, 256, 265, 271, 274, 298, 299 💬
117Calcium and cholecalciferol2件: Calcium,
Cholecalciferol		1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 46 💬
118Calcium and Vit D1件: Calcium---1件: 49 💬
119Calcium and Vitamin D2件: Calcium,
Vitamin D		---1件: 74 💬
120Calcium and Vitamin D combination2件: Calcium,
Vitamin D		---1件: 13 💬
121Calcium carbonate2件: Calcium,
Calcium carbonate		2件: Calcium carbonate ,
Calcium carbonate 💬 		--10件: 13, 19, 46, 53, 71, 75, 96, 97, 235, 299 💬
122Calcium carbonate 1250 mg (500 mg elemental calcium) 4 times a day2件: Calcium,
Calcium carbonate		2件: Calcium carbonate ,
Calcium carbonate 💬 		--1件: 235 💬
123Calcium carbonate 1250 mg (500 mg elemental calcium) twice a day2件: Calcium,
Calcium carbonate		2件: Calcium carbonate ,
Calcium carbonate 💬 		--1件: 235 💬
124Calcium carbonate 600 mg once daily2件: Calcium,
Calcium carbonate		2件: Calcium carbonate ,
Calcium carbonate 💬 		--1件: 97 💬
125Calcium carbonate and alphacalcidol2件: Calcium,
Calcium carbonate		2件: Calcium carbonate ,
Calcium carbonate 💬 		--1件: 235 💬
126Calcium carbonate D2件: Calcium,
Calcium carbonate		2件: Calcium carbonate ,
Calcium carbonate 💬 		--1件: 53 💬
127Calcium carbonate tablets2件: Calcium,
Calcium carbonate		2件: Calcium carbonate ,
Calcium carbonate 💬 		--1件: 46 💬
128Calcium Channel Blockers1件: Calcium---1件: 51 💬
129Calcium citrate2件: Calcium,
Calcium citrate		1件: Calcium citrate 💬 --3件: 46, 84, 235 💬
130Calcium Citrate with Vitamin D23件: Calcium,
Calcium citrate,
Ergocalciferol		2件: Ergocalciferol ,
Calcium citrate 💬 		1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 84 💬
131Calcium D31件: Calcium---1件: 274 💬
132CALCIUM D3 SANDOZ - 1000 MG + 880 U.I. COMPRESSE EFFERVESCENTI 30 COMPRESSE DIVISIBILI1件: Calcium---1件: 274 💬
133Calcium gluconate2件: Calcium,
Calcium gluconate		1件: Calcium gluconate 💬 --3件: 214, 215, 235 💬
134Calcium lactate2件: Calcium,
Calcium lactate		1件: Calcium lactate 💬 --1件: 235 💬
135Calcium levofolinate1件: Calcium---1件: 13 💬
136Calcium Phosphate2件: Calcium,
Calcium Phosphate		2件: Anhydrous diabasic calcium phosphate ,
Calcium phosphate, tribasic 💬 		--1件: 71 💬
137Calcium rosuvastatin2件: Calcium,
Rosuvastatin		2件: Rosuvastatin calcium ,
Rosuvastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬1件: 79 💬
138Calcium, Dietary1件: Calcium---1件: 298 💬
139Calculus bovis sativus (CBS)----1件: 13 💬
140CALD HR-D (High-Risk, Regimen C)----5件: 19, 20, 125, 234, 326 💬
141CALD HR-D (High-Risk, Regimen D)----5件: 19, 20, 125, 234, 326 💬
142CALD SR-A (Standard-Risk, Regimen A)----5件: 19, 20, 125, 234, 326 💬
143CALD SR-B (Standard-Risk, Regimen B)----5件: 19, 20, 125, 234, 326 💬
144Calfactant1件: Calfactant1件: Calfactant 💬 --1件: 299 💬
145Calogen----1件: 2 💬
146Caltrate----1件: 97 💬
147Caltrate Pill----1件: 96 💬
148Calvan (bevantolol hydrochloride)1件: Bevantolol1件: Bevantolol hydrochloride 💬 8件: ADRA1A,
ADRA1B,
ADRA1D,
ADRB1,
CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬 		44件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gap junction, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hormone signaling, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 8 💬
149Calvan Tablets 100----1件: 8 💬
150Calvan® 100 mg----1件: 8 💬
151CALY-0021件: CALY-002---1件: 98 💬
152CAM-30011件: Mavrilimumab1件: Mavrilimumab 💬 1件: CSF2RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 46 💬
153CAM2029----1件: 77 💬
154CAM2029 (Octreotide subcutaneous depot)1件: Octreotide5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
155CAM2029 (Octreotide subcutaneous depot) _prefilled syringe_prefilled syringe1件: Octreotide5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
156CAM2029 (Octreotide subcutaneous depot)_ prefilled pen1件: Octreotide5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
157CAM2029 (Octreotide subcutaneous depot)_ prefilled syringe1件: Octreotide5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
158CAM2029 (Octreotide subcutaneous depot)_pre-filled pen1件: Octreotide5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
159CAM2029 (Octreotide subcutaneous depot)_pre-filled syringe1件: Octreotide5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
160CAM2029 (Octreotide subcutaneous depot)_prefilled pen1件: Octreotide5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
161CAM2029 (Octreotide subcutaneous depot)_prefilled syringe1件: Octreotide5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
162CAM2029-BR----1件: 77 💬
163CAM2043----1件: 51 💬
164Camoteskimab1件: Camoteskimab---1件: 54 💬
165Camoteskimab (CERC-007, AVTX-007, AEVI-007)1件: Camoteskimab---1件: 54 💬
166Campath----3件: 49, 51, 60 💬
167Campath -1H----1件: 65 💬
168Campath 1H----4件: 60, 65, 164, 285 💬
169Campath, Busulfan, Clofarabine2件: Busulfan,
Clofarabine		2件: Busulfan ,
Clofarabine 💬 		3件: POLA1,
POLA2,
RRM1 💬 		5件: DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 326 💬
170Campath, Chemo and/or TBI Allo SCT----3件: 60, 62, 283 💬
171Campath, Fludarabine, Cyclophosphamide2件: Cyclophosphamide,
Fludarabine		4件: Cyclophosphamide ,
Fludarabine phosphate ,
Cyclophosphamide ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 65, 284 💬
172Campath-1H----6件: 19, 20, 60, 65, 234, 326 💬
173CAMPATH-1H (Alemtuzumab)1件: Alemtuzumab1件: Alemtuzumab 💬 --1件: 60 💬
174Canakinumab1件: Canakinumab1件: Canakinumab 💬 1件: IL1B 💬 43件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
175Canakinumab (ACZ885)1件: Canakinumab1件: Canakinumab 💬 1件: IL1B 💬 43件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬1件: 106 💬
176Canakinumab (company code: ACZ885D)1件: Canakinumab1件: Canakinumab 💬 1件: IL1B 💬 43件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬1件: 106 💬
177Canakinumab (investigational)1件: Canakinumab1件: Canakinumab 💬 1件: IL1B 💬 43件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬1件: 46 💬
178Canakinumab (proposed)1件: Canakinumab1件: Canakinumab 💬 1件: IL1B 💬 43件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬1件: 46 💬
179Canakinumab (WHO approval pending)1件: Canakinumab1件: Canakinumab 💬 1件: IL1B 💬 43件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬1件: 106 💬
180Canakinumab - proposed1件: Canakinumab1件: Canakinumab 💬 1件: IL1B 💬 43件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬1件: 106 💬
181Canakinumab Injection1件: Canakinumab1件: Canakinumab 💬 1件: IL1B 💬 43件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬1件: 46 💬
182Canakinumab Injection [Ilaris]1件: Canakinumab1件: Canakinumab 💬 1件: IL1B 💬 43件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬1件: 113 💬
183CANDESARTAN1件: Candesartan1件: Candesartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬4件: 57, 58, 67, 222 💬
184Candesartan and Cilnidipine2件: Candesartan,
Cilnidipine		2件: Candesartan ,
Cilnidipine 💬 		6件: AGTR1,
CACNA1B,
CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬 		50件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Apelin signaling pathway, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hormone signaling, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prion disease, Renin secretion, Renin-angiotensin system, Retrograde endocannabinoid signaling, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 67 💬
185Candesartan plus non-CCB agents1件: Candesartan1件: Candesartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 67 💬
186Candesartán Kern Pharma 16 mg comprimidos EFG----1件: 57 💬
187Cannabichromene1件: Cannabichromene---1件: 46 💬
188Cannabidiol1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬20件: 6, 8, 13, 19, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬
189Cannabidiol (CBD)1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬7件: 6, 13, 140, 144, 145, 156, 158 💬
190Cannabidiol , synthetic form1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 96 💬
191Cannabidiol / Dronabinol capsule 5 mg+2,5 mg2件: Cannabidiol,
Dronabinol		2件: Dronabinol ,
Cannabidiol 💬 		2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
192Cannabidiol 100 mg/ml1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 6 💬
193Cannabidiol 300 mg/ml1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 6 💬
194Cannabidiol 400 mg/ml1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 6 💬
195Cannabidiol Botanical Drug Substance (CBD BDS)1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
196Cannabidiol capsule 5 mg1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
197Cannabidiol Oral Solution1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬4件: 140, 144, 145, 193 💬
198Cannabidiol oral solution (Epidyolex)1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬3件: 19, 158, 206 💬
199Cannabidiol Oral Solution [Epidiolex]1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 158 💬
200Cannabidiol Oral Solution, is known as Epidyolex 100 mg/mL oral solution and is the approved name in the EU. Epidiolex (cannabidiol) oral solution is the approved name in the US.1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 158 💬
201Cannabidiol tablet 10 mg1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬2件: 46, 271 💬
202Cannabidiol vaginal suppository1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 226 💬
203Cannabidiolo----1件: 156 💬
204Cannabidiolo (CBD)----1件: 156 💬
205Cannabigerol1件: Cannabigerol---1件: 46 💬
206Cannabigerol (CBG)1件: Cannabigerol---1件: 46 💬
207CANNABINOL1件: Cannabinol---1件: 36 💬
208Cannabinol (CBN)1件: Cannabinol---1件: 36 💬
209Cannabis----2件: 13, 90 💬
210Cannabis Based Medicine Extract (Sativex)----1件: 13 💬
211Cannabis Oil----1件: 6 💬
212Cannabis Sativa extract Oromucosal spray----1件: 2 💬
213Cannabis sativa L., folium cum flore----1件: 19 💬
214Cannabis, Medical----5件: 2, 6, 13, 96, 97 💬
215Cannador----1件: 13 💬
216CAP-1002----1件: 113 💬
217Capacity of muscular oxygen extraction1件: Oxygen1件: Oxygen 💬 --1件: 13 💬
218Capecitabine1件: Capecitabine1件: Capecitabine 💬 1件: TYMS 💬 3件: Folate transport and metabolism, One carbon pool by folate, Pyrimidine metabolism 💬1件: 94 💬
219CAPILLAREMA----1件: 51 💬
220Capillary colchicine dosage in colchicine-resistant Familial Mediterranean Fever patients.1件: Colchicine1件: Colchicine 💬 9件: TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		12件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬1件: 266 💬
221Caplacizumab1件: Caplacizumab1件: Caplacizumab 💬 1件: VWF 💬 9件: Complement and coagulation cascades, Coronavirus disease, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Integrin signaling, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬2件: 63, 64 💬
222Caplacizumab (ALX-0081)1件: Caplacizumab1件: Caplacizumab 💬 1件: VWF 💬 9件: Complement and coagulation cascades, Coronavirus disease, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Integrin signaling, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬1件: 64 💬
223Caplacizumab (an anti-von Willebrand Factor Nanobody ALX-0081)1件: Caplacizumab1件: Caplacizumab 💬 1件: VWF 💬 9件: Complement and coagulation cascades, Coronavirus disease, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Integrin signaling, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬1件: 64 💬
224Caplacizumab (an anti-von Willebrand Factor Nanobody)1件: Caplacizumab1件: Caplacizumab 💬 1件: VWF 💬 9件: Complement and coagulation cascades, Coronavirus disease, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Integrin signaling, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬1件: 64 💬
225Caprylic Triglyceride----1件: 13 💬
226Capsaicin1件: Capsaicin1件: Capsaicin 💬 1件: TRPV1 💬 2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬5件: 2, 6, 19, 86, 226 💬
227Capsaicin Challenge1件: Capsaicin1件: Capsaicin 💬 1件: TRPV1 💬 2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 2 💬
228Capsaicin vapor1件: Capsaicin1件: Capsaicin 💬 1件: TRPV1 💬 2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 6 💬
229Capsule di prednisone1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
230Capsule endoscopy----1件: 96 💬
231Capsule fecal microbiota material (cap-FMT)1件: Fecal microbiota---1件: 96 💬
232Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg)3件: Carbidopa,
Entacapone,
Levodopa		3件: Levodopa ,
Carbidopa ,
Entacapone 💬 		7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		18件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
233Capsules with 160 mg Teavigo (at least 94% EGCG)----1件: 13 💬
234Captafer®----1件: 97 💬
235Captopril1件: Captopril1件: Captopril 💬 1件: ACE 💬 6件: Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬3件: 17, 57, 86 💬
236CAR T cell----1件: 50 💬
237CAR-DC----1件: 85 💬
238CAR-NK cell----1件: 53 💬
239CAR-T cell----1件: 49 💬
240CAR-T cells----1件: 63 💬
241CAR-T cells injection----1件: 13 💬
242CAR-T Therapy----2件: 49, 51 💬
243Carbaglu----2件: 245, 246 💬
244Carbamazepine1件: Carbamazepine1件: Carbamazepine 💬 6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		5件: Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬6件: 6, 13, 137, 145, 158, 231 💬
245Carbetocin1件: Carbetocin1件: Carbetocin 💬 1件: OXTR 💬 5件: Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬1件: 193 💬
246CARBIDOPA1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬7件: 6, 13, 17, 90, 140, 164, 201 💬
247CARBIDOPA (CD)1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
248CARBIDOPA (FU)1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
249Carbidopa 20 mg1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
250Carbidopa 200mg oral dose1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬2件: 6, 17 💬
251Carbidopa 25/Levodopa 100Mg Tab2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
252Carbidopa 27.5 mg1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
253Carbidopa 65 mg capsule1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
254Carbidopa and Levodopa Controlled Release Tablets2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
255Carbidopa and Levodopa Tablets, USP2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
256CARBIDOPA ANIDRA1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
257CARBIDOPA FU1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
258CARBIDOPA INN1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
259CARBIDOPA LEVODOPA2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
260CARBIDOPA MONOHYDRATE1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
261Carbidopa Pill1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
262Carbidopa, levodopa, entacapone3件: Carbidopa,
Entacapone,
Levodopa		3件: Levodopa ,
Carbidopa ,
Entacapone 💬 		7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		18件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
263Carbidopa- Levodopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
264Carbidopa-4'-Monophosphate1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
265Carbidopa-Levodopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
266Carbidopa-Levodopa 25 Mg-100 Mg Oral Tablet2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
267Carbidopa/l-dopa1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
268Carbidopa/l-dopa/entacapone2件: Carbidopa,
Entacapone		2件: Carbidopa ,
Entacapone 💬 		2件: COMT,
DDC 💬 		9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
269Carbidopa/levodopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
270Carbidopa/levodopa, as prescribed by treating physician2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
271Carbidopa/Levodopa, immediate release2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
272Carbidopa/Levodopa/Entacapone3件: Carbidopa,
Entacapone,
Levodopa		3件: Levodopa ,
Carbidopa ,
Entacapone 💬 		7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		18件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
273Carbidopamonohydraat----1件: 6 💬
274CARBODOPA LEVADOPA----1件: 6 💬
275Carbodopa/levadopa----1件: 6 💬
276Carbohydrates----1件: 240 💬
277Carbohydrates intake----1件: 257 💬
278CARBOLITHIUM----1件: 2 💬
279CARBOLITHIUM*100CPS 150MG----1件: 2 💬
280Carbomer1件: Carbomer---1件: 53 💬
281Carbomer 974P1件: Carbomer---1件: 53 💬
282Carbomer Gel/Jelly1件: Carbomer---1件: 53 💬
283Carbon dioxide1件: Carbon dioxide1件: Carbon dioxide 💬 --4件: 50, 51, 97, 158 💬
284Carbon dioxide insufflation1件: Carbon dioxide1件: Carbon dioxide 💬 --1件: 97 💬
285Carbon Fiber Ankle Foot Orthosis (AFO)----1件: 6 💬
286Carbon monoxide1件: Carbon monoxide1件: Carbon monoxide 💬 --3件: 85, 86, 298 💬
287Carbon orthosis (control)----1件: 13 💬
288Carbon-14 BIA 28-61561件: BIA---1件: 6 💬
289Carbon-14 labeled HSK39297----1件: 62 💬
290Carbonate de lithium----1件: 2 💬
291CARBONE VEGETALE----1件: 13 💬
292Carbone vegetale polvere----1件: 13 💬
293Carboplatin1件: Carboplatin1件: Carboplatin 💬 --4件: 28, 34, 60, 85 💬
294CARBOSSIMALTOSIO FERRICO----1件: 97 💬
295Carboxymethylcellulose1件: Carboxymethylcellulose2件: Carboxymethylcellulose sodium ,
Carmellose 💬 		--3件: 35, 70, 162 💬
296Carboxymethylcellulose with ionic silver (Aquacel Ag)2件: Carboxymethylcellulose,
Silver		2件: Carboxymethylcellulose sodium ,
Carmellose 💬 		--2件: 35, 162 💬
297CardAP-Zellen----1件: 57 💬
298CardAPcells----1件: 57 💬
299Cardiac Index-Guided Hemodynamic Management----1件: 22 💬
300Cardiac Magnetic Resonance Imaging (CMRI)----1件: 215 💬
301Cardiac monitoring----1件: 6 💬
302Cardiac MRI (CMR)----2件: 215, 216 💬
303Cardicor (Merck brand)----1件: 113 💬
304CardioMEMS pulmonary artery pressure monitor----1件: 86 💬
305Cardiovascular profile----1件: 113 💬
306CARDURA----1件: 67 💬
307CARDYL 10 mg comprimidos recubiertos con película----1件: 79 💬
308CARDYL 20 mg comprimidos recubiertos con película----1件: 79 💬
309CARDYL 40 mg comprimidos recubiertos con película----1件: 79 💬
310Care as usual----1件: 15 💬
311Carfentanil1件: Carfentanil2件: Carfentanil citrate ,
Carfentanil 💬 		1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 6 💬
312Carfilzomib1件: Carfilzomib1件: Carfilzomib 💬 1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬2件: 16, 28 💬
313CARFILZOMIB, CYCLOPHOSPHAMIDE, DEXAMETHASONE3件: Carfilzomib,
Cyclophosphamide,
Dexamethasone		6件: Cyclophosphamide ,
Dexamethasone ,
Dexamethasone sodium phosphate ,
Cyclophosphamide ,
Dexamethasone phosphate ,
Carfilzomib 💬 		2件: NR3C1,
PSMB5 💬 		9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 16 💬
314Carglumic Acid1件: Carglumic acid1件: Carglumic acid 💬 1件: CPS1 💬 3件: Alanine, aspartate and glutamate metabolism, Arginine biosynthesis, Nitrogen metabolism 💬3件: 245, 246, 251 💬
315Carglumic Acid (Carbaglu®)1件: Carglumic acid1件: Carglumic acid 💬 1件: CPS1 💬 3件: Alanine, aspartate and glutamate metabolism, Arginine biosynthesis, Nitrogen metabolism 💬2件: 245, 246 💬
316CARISBAMATE1件: Carisbamate1件: Carisbamate 💬 --1件: 144 💬
317Carisbamate (S)-2-O-carbamoyl-1-o-chlorophenyl-ethanol2件: Carisbamate,
Ethanol		3件: Alcohol ,
Ethanol ,
Carisbamate 💬 		--1件: 144 💬
318CARMUSTINA----1件: 13 💬
319Carmustine1件: Carmustine1件: Carmustine 💬 --5件: 11, 13, 14, 28, 60 💬
320Carmustine, etoposide, cytarabine, and melphalan (BEAM)4件: Carmustine,
Cytarabine,
Etoposide,
Melphalan		7件: Etoposide ,
Cytarabine ,
Carmustine ,
Melphalan ,
Cytarabine hydrochloride ,
Etoposide phosphate ,
Melphalan hydrochloride 💬 		--1件: 13 💬
321Carnitine----2件: 46, 58 💬
322Carnosine1件: Carnosine---2件: 6, 13 💬
323Carnosine supplementation1件: Carnosine---1件: 6 💬
324Carnosine, capsulle, 2 g/day, 8 weeks1件: Carnosine---1件: 13 💬
325Carotegrast methyl1件: Carotegrast methyl1件: Carotegrast methyl 💬 3件: ITGA4,
ITGB1,
ITGB7 💬 		32件: Arrhythmogenic right ventricular cardiomyopathy, Axon guidance, Bacterial invasion of epithelial cells, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pertussis, Phagocytosis, Platelet activation, Proteoglycans in cancer, Rap1 signaling pathway, Regulation of actin cytoskeleton, Shigellosis, Small cell lung cancer, Tight junction, Toxoplasmosis, Transcriptional misregulation in cancer, Virion - Rotavirus, Yersinia infection 💬1件: 97 💬
326Carotid to femoral PWW measurement----1件: 167 💬
327Carrageenan----1件: 97 💬
328CART Infusion----2件: 61, 63 💬
329CART19----1件: 49 💬
330Carvedilol1件: Carvedilol2件: Carvedilol ,
Carvedilol phosphate 💬 		5件: ADRA1A,
ADRA1B,
ADRA1D,
ADRB1,
ADRB2 💬 		15件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬7件: 6, 46, 57, 58, 86, 113, 210 💬
331CARVI EXTRACTUM FLUIDUM----1件: 97 💬
332CAS # in D.3.9.1 for Sodium Salt. CAS number 1639325-43-1 (Parent Acid)----1件: 254 💬
333CAS Name: 1,4-Benzoxazepin-5(2H)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4-----1件: 58 💬
334CAS Name: 1,4-Benzoxazepin-5(2H)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4- (trifluoromethoxy)phenyl] IUPAC Name: 4-(Pyrimidin-2-ylmethyl)-7-[4- (trifluoromethoxy)phenyl]-3,4-dihydro-1,4-benzoxazepin-5(2H)-one----1件: 58 💬
335CAS Name: 1,4-Benzoxazepin-5(2H)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4-(trifluoromethoxy)phenyl] IUPAC Name: 4-(Pyrimidin-2-ylmethyl)-7-[4-(trifluoromethoxy)phenyl]-3,4-dihydro-1,4-benzoxazepin-5(2H)-one----1件: 58 💬
336CAS No.: 7758-16-9----1件: 166 💬
337CAS# in D.3.9.1 for Sodium Salt. CAS number 1639325-43-1 (Parent Acid)----1件: 254 💬
338Casein1件: Casein---1件: 97 💬
339Casein glycomacropeptide (CGMP)1件: Casein---1件: 97 💬
340CASIMERSEN1件: Casimersen1件: Casimersen 💬 1件: DMD 💬 5件: Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113 💬
341Caspofungin1件: Caspofungin2件: Caspofungin acetate ,
Caspofungin 💬 		--1件: 60 💬
342CASPOFUNGIN ACETATE2件: Acetate,
Caspofungin		2件: Caspofungin acetate ,
Caspofungin 💬 		--1件: 60 💬
343CAT-1004----1件: 113 💬
344CAT-354----1件: 97 💬
345Catapres ampoules----1件: 6 💬
346Catapresan 75, Tabletten----1件: 65 💬
347Cathepsin S----1件: 53 💬
348Cathepsin S Inhibitor----1件: 53 💬
349Catheter directed therapy----1件: 88 💬
350Catridecacog1件: Catridecacog1件: Catridecacog 💬 --1件: 97 💬
351Caudal epidural injection----1件: 70 💬
352Caudal Epidural Injection with Celestone----1件: 70 💬
353Caudal Epidural Injection with DepoMedrol----1件: 70 💬
354Caudal Epidural Injection with generic Celestone----1件: 70 💬
355Caveolin-1-Scaffolding-Protein-Derived Peptide (LTI-03)1件: LTI-03---1件: 85 💬
356Cavosonstat1件: Cavosonstat1件: Cavosonstat 💬 --1件: 299 💬
357Cayston----1件: 299 💬
358Cayston 75 mg Pulver und Lösungsmittel zur Herstellung einer Lösung für einen Vernebler----1件: 299 💬
359CAYSTON aztreonam 75 mg powder and solvent for nebuliser solution1件: Aztreonam2件: Aztreonam ,
Aztreonam lysine 💬 		--1件: 299 💬
360CB-01-02----1件: 97 💬
361CB-01-05-MMX----1件: 97 💬
362CB-0101件: CB-010---1件: 49 💬
363CB-280----1件: 299 💬
364CBD----2件: 13, 36 💬
365CBD - Oral Solution, is known as Epidiolex, and is the approved name in the USA.----2件: 140, 144 💬
366CBD - Oral Solution, is known as Epidyolex 100 mg/ml oral solution,----1件: 158 💬
367CBD - Oral Solution, is known as Epidyolex, and is the approved name----1件: 156 💬
368CBD - Solution Orale, conosciuto come Epidiolex, questo è il nome approvato negli Stati Uniti----1件: 156 💬
369CBD oil----1件: 51 💬
370CBD Oral Solution----1件: 206 💬
371CBD Oral Solution (eCBD system Target)----1件: 206 💬
372CBD Oral solution, is known as Epidyolex and is the approved name in the EU----1件: 156 💬
373CBD soluzione orale nota come Epidyolex e con tale nome è stato approvato in UE----1件: 156 💬
374CBD, synthetic form----1件: 97 💬
375CBD-Oral Solution, is known as Epidiolex, and is the approved name in the USA.----1件: 158 💬
376CBD: GT4 Transdermal Delivery System----2件: 140, 144 💬
377CBDV Compound----1件: 193 💬
378CBP-307----1件: 97 💬
379CBT102-A capsule----1件: 240 💬
380CC-100004----1件: 84 💬
381CC-10004----5件: 46, 56, 97, 162, 271 💬
382CC-220----1件: 49 💬
383CC-220 0.3 mg Daily----1件: 84 💬
384CC-220 0.6mg Daily----1件: 84 💬
385CC-292----1件: 46 💬
386CC-4047----2件: 28, 51 💬
387CC-5013----2件: 28, 96 💬
388CC-900011件: CC-90001---1件: 85 💬
389CC-930----1件: 85 💬
390CC-93538----1件: 98 💬
391CC-97540----5件: 11, 13, 46, 49, 51 💬
392CC-97540 (BMS-986353)----1件: 13 💬
393CC-99677----1件: 271 💬
394CC-99677 30mg Capsule----1件: 271 💬
395CC-99677 60mg Capsule----1件: 271 💬
396CC100----1件: 2 💬
397CC312----5件: 46, 49, 51, 61, 63 💬
398CCD 1042----1件: 152 💬
399CCD 1042, MD 9150000, Mepalon 1042, SPT316----2件: 152, 206 💬
400CCD 1042, MD 9150000, Mepalon 1042, SPT3162----1件: 152 💬
401CCI-779----2件: 13, 46 💬
402CCP-020----1件: 36 💬
403CCR1 Antagonist----1件: 46 💬
404CCX 354----1件: 46 💬
405CCX 354-C----1件: 46 💬
406CCX-3541件: CCX-354---1件: 46 💬
407CCX-354-C1件: CCX-354---1件: 46 💬
408CCX140-B----1件: 222 💬
409CCX168----6件: 43, 44, 49, 66, 109, 223 💬
410CCX282-B----1件: 96 💬
411CCX354----1件: 46 💬
412CCX354-C----1件: 46 💬
413CD-4 guided therapy interruption----1件: 265 💬
414CD-C-Food----1件: 96 💬
415CD-LD CR----1件: 6 💬
416CD-LD IR----1件: 6 💬
417CD19 CAR T Arm----1件: 51 💬
418CD19 CAR-?d T cell----2件: 66, 222 💬
419CD19 CAR-T cell infusion----1件: 49 💬
420CD19 CAR-T cells----1件: 49 💬
421CD19 or CD19-BCMA CAR-T----2件: 51, 53 💬
422CD19 targeted CAR-T cells----3件: 50, 51, 53 💬
423CD19 UCAR-T cells----5件: 48, 49, 51, 53, 63 💬
424CD19 Universal CAR-?d T Cells----1件: 49 💬
425CD19 Universal CAR-T cells----1件: 49 💬
426CD19- BCMA CAR-T cells----4件: 43, 49, 51, 53 💬
427CD19-BCMA CAR-T cells infusion----3件: 49, 51, 53 💬
428CD19-BCMA Targeted CAR-T Dose 1----1件: 11 💬
429CD19-BCMA Targeted CAR-T Dose 2----1件: 11 💬
430CD19-CAR-DNT cells----2件: 49, 51 💬
431CD19-CAR-NK Cells Injection----1件: 11 💬
432CD19-directed humanised afucosylated monoclonal antibody----1件: 11 💬
433CD19-targetd CAR-T----1件: 50 💬
434CD19-targeted iNKT Cell Injection----3件: 66, 222, 223 💬
435CD19/BCMA CAR NK----1件: 300 💬
436CD19/BCMA CAR T-cells----3件: 16, 49, 61 💬
437CD19/BCMA CAR-T cell therapy----1件: 49 💬
438CD19/BCMA-targeted CAR-T cells----3件: 11, 13, 14 💬
439CD19/BCMA-Targeted Universal Chimeric Antigen Receptor T Cells (UCAR-T) infusing----1件: 222 💬
440CD19/CD22/BCMA CAR-T cells(BZE2204)----2件: 49, 63 💬
441CD20/BCMA-directed CAR-T cells----4件: 11, 13, 49, 51 💬
442CD3-depleted hematopoietic cell transplantation----1件: 60 💬
443CD3/CD19 depleted leukocytes----1件: 284 💬
444CD3/CD19 neg allogeneic BMT----1件: 65 💬
445CD3/CD19 negative allogeneic hematopoietic stem cells----1件: 65 💬
446CD3/CD19 negative hematopoietic stem cells----1件: 85 💬
447CD34 selected autologous hematopoietic cells----1件: 51 💬
448CD34 selected haploidentical PBSCT----1件: 285 💬
449CD34 Stem Cell Selection Therapy----3件: 60, 65, 284 💬
450CD34+----1件: 65 💬
451CD34+ autologous stem cell transplantation----1件: 57 💬
452CD34+ bone marrow stem cells intravitreal----1件: 90 💬
453CD34+ cell enriched stem cell graft----2件: 65, 285 💬
454CD34+ CELLS----1件: 285 💬
455CD34+ cells enriched with MNV-BLD----1件: 21 💬
456CD34+ enriched, T Cell Depleted donor stem cell product----1件: 326 💬
457CD34+ HSCs transduced with the lentivirus vector, VSV-G pseudotyped CL20-4i-EF1a-h?c-OPT----1件: 65 💬
458CD34+ Peripheral Blood Stem Cell Reinfusion----1件: 49 💬
459CD34+ selected cells----1件: 285 💬
460CD34+CELLS----2件: 65, 285 💬
461CD34+SC----1件: 51 💬
462CD3±CD19 depleted hematopoietic stem cell transplantation----1件: 60 💬
463CD4-IgG----1件: 63 💬
464CD45RA depleted leukocytes----1件: 284 💬
465CD45RA-depleted DLI----1件: 60 💬
466CD62L- Tem----1件: 60 💬
467CD7 CAR T-cells----3件: 50, 96, 97 💬
468CD7 CAR-T cells infusion----1件: 60 💬
469CD7 CAR-T cells injection----1件: 60 💬
470CDC infusion----1件: 57 💬
471CDCA Weight-Based Dose TID----1件: 263 💬
472CDED+dairy----1件: 96 💬
473CDED+PEN----1件: 96 💬
474CDMARD----1件: 46 💬
475CDNF----1件: 6 💬
476CDP 6038 SC----1件: 46 💬
477CDP3194----1件: 49 💬
478CDP3231件: CDP323---1件: 13 💬
479CDP6038----2件: 46, 96 💬
480CDP6038 (olokizumab)1件: Olokizumab1件: Olokizumab 💬 1件: IL6 💬 49件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬1件: 46 💬
481CDP7657----1件: 49 💬
482CDP870----3件: 46, 96, 271 💬
483CDP870 100mg----1件: 46 💬
484CDP870 200mg----1件: 46 💬
485CDP870 400mg----1件: 46 💬
486CDP870 Fab'-PEG----1件: 46 💬
487CDX 6114----1件: 240 💬
488CDX-0159----1件: 98 💬
489CDX-11351件: CDX-1135---1件: 223 💬
490CDZ173----2件: 53, 65 💬
491CE 224,535----1件: 46 💬
492CE-224,535----1件: 46 💬
493CE-VST01-JC1件: CE-VST01-JC---1件: 25 💬
494CE1145----1件: 65 💬
495CE211NS21----1件: 13 💬
496CEBION 500*20CPR MAST 500MG----1件: 10 💬
497CEBION 500MG 20CPR MAST.ARAN----1件: 10 💬
498Cebsulfase alfa----1件: 19 💬
499Cediranib1件: Cediranib2件: Cediranib ,
Cediranib maleate 💬 		3件: FLT1,
FLT4,
KDR 💬 		17件: Breast cancer, Cadherin signaling, Calcium signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, IgSF CAM signaling, Integrin signaling, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Rheumatoid arthritis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬1件: 34 💬
500Cediranib Maleate1件: Cediranib2件: Cediranib ,
Cediranib maleate 💬 		3件: FLT1,
FLT4,
KDR 💬 		17件: Breast cancer, Cadherin signaling, Calcium signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, IgSF CAM signaling, Integrin signaling, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Rheumatoid arthritis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬1件: 34 💬
501Cefaclor1件: Cefaclor2件: Cefaclor ,
Cefaclor 💬 		--1件: 296 💬
502CEFALEXIN----1件: 299 💬
503Cefazolin1件: Cefazolin2件: Cefazolin sodium ,
Cefazolin 💬 		--1件: 291 💬
504CEFAZOLINA----1件: 90 💬
505Cefazolina Qilu----1件: 90 💬
506Cefepime1件: Cefepime2件: Cefepime hydrochloride ,
Cefepime 💬 		--2件: 60, 299 💬
507CEFEPIME DIHYDROCHLORIDE MONOHYDRATE1件: Cefepime2件: Cefepime hydrochloride ,
Cefepime 💬 		--1件: 60 💬
508Cefiderocol1件: Cefiderocol2件: Cefiderocol sulfate tosylate ,
Cefiderocol 💬 		--3件: 96, 97, 299 💬
509Cefmetazole1件: Cefmetazole2件: Cefmetazole ,
Cefmetazole sodium 💬 		--2件: 96, 97 💬
510Cefoperazone1件: Cefoperazone2件: Cefoperazone sodium ,
Cefoperazone 💬 		--1件: 296 💬
511Cefoxitin1件: Cefoxitin2件: Cefoxitin sodium ,
Cefoxitin 💬 		--1件: 299 💬
512Ceftaroline----1件: 299 💬
513Ceftazidim Fresenius Kabi1件: Ceftazidime2件: Ceftazidime ,
Ceftazidime 💬 		--1件: 299 💬
514Ceftazidim Fresenius Kabi 2000 mg poeder voor oplossing voor injectie of infusie1件: Ceftazidime2件: Ceftazidime ,
Ceftazidime 💬 		--1件: 299 💬
515CEFTAZIDIMA PENTAIDRATO1件: Ceftazidime2件: Ceftazidime ,
Ceftazidime 💬 		--1件: 299 💬
516CEFTAZIDIME1件: Ceftazidime2件: Ceftazidime ,
Ceftazidime 💬 		--1件: 299 💬
517Ceftazidime and tobramycin2件: Ceftazidime,
Tobramycin		4件: Tobramycin ,
Ceftazidime ,
Tobramycin sulfate ,
Ceftazidime 💬 		--1件: 299 💬
518CEFTAZIDIME PENTAHYDRATE1件: Ceftazidime2件: Ceftazidime ,
Ceftazidime 💬 		--1件: 299 💬
519Ceftazidime/avibactam2件: Avibactam,
Ceftazidime		3件: Ceftazidime ,
Ceftazidime ,
Avibactam sodium 💬 		--1件: 299 💬
520Ceftolozane1件: Ceftolozane2件: Ceftolozane ,
Ceftolozane sulfate 💬 		--1件: 299 💬
521Ceftolozane/Tazobactam2件: Ceftolozane,
Tazobactam		4件: Tazobactam ,
Tazobactam sodium ,
Ceftolozane ,
Ceftolozane sulfate 💬 		--1件: 299 💬
522Ceftriaxone1件: Ceftriaxone2件: Ceftriaxone sodium ,
Ceftriaxone 💬 		--4件: 2, 6, 97, 299 💬
523Ceftriaxone for Injection1件: Ceftriaxone2件: Ceftriaxone sodium ,
Ceftriaxone 💬 		--1件: 299 💬
524Cefuroxim1件: Cefuroxime3件: Cefuroxime ,
Cefuroxime axetil ,
Cefuroxime sodium 💬 		--1件: 299 💬
525CEFUROXIMA----1件: 90 💬
526Cefuroxime1件: Cefuroxime3件: Cefuroxime ,
Cefuroxime axetil ,
Cefuroxime sodium 💬 		--2件: 97, 299 💬
527CELBESTA®----1件: 46 💬
528Celebra----1件: 46 💬
529Celebra (celecoxib)1件: Celecoxib1件: Celecoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
530CELEBREX----4件: 46, 96, 107, 271 💬
531Celebrex 200 mg----1件: 46 💬
532Celebrex 200 mg capsule, hard----1件: 46 💬
533Celebrex 200 mg Hartkapseln----1件: 46 💬
534CELEBREX 200MG 20CPS----1件: 46 💬
535Celebrex 200Mg Capsule----1件: 70 💬
536Celebrex, Celcox----1件: 2 💬
537CELEBREX®----1件: 46 💬
538CELECOXIB1件: Celecoxib1件: Celecoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬14件: 2, 3, 6, 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
539Celecoxib (Celebrex)1件: Celecoxib1件: Celecoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 34 💬
540Celecoxib 200 milligrams1件: Celecoxib1件: Celecoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
541Celecoxib 200mg1件: Celecoxib1件: Celecoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 6 💬
542Celecoxib 200mg capsule1件: Celecoxib1件: Celecoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
543Celecoxib 400 milligrams1件: Celecoxib1件: Celecoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
544Celecoxib, Celebrex®1件: Celecoxib1件: Celecoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
545Celiac Block with triamcinolone and bupivicaine1件: Triamcinolone4件: Triamcinolone ,
Triamcinolone acetonide ,
Triamcinolone diacetate ,
Triamcinolone hexacetonide 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 298 💬
546Celiprolol1件: Celiprolol2件: Celiprolol hydrochloride ,
Celiprolol 💬 		1件: ADRB1 💬 13件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 168 💬
547Cell----1件: 57 💬
548Cell Infusion----3件: 60, 62, 283 💬
549Cell suspension containing dendritic cells----1件: 13 💬
550Cell transplantation----1件: 36 💬
551Cell-based therapeutics----1件: 2 💬
552Cell-based therapy----1件: 2 💬
553Cell-based therapy of autologous adipose derived regenerative cells transplanted intraspinally and intrathecally in ALS patients----1件: 2 💬
554Cellavita HD Higher dose----1件: 8 💬
555Cellavita HD Lower Dose----1件: 8 💬
556Cellavita-HD----1件: 8 💬
557CELLCEPT----7件: 11, 13, 42, 43, 49, 222, 223 💬
558CellCept (Mycophenolate Mofetil)1件: Mycophenolate mofetil2件: Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride 💬 		2件: IMPDH1,
IMPDH2 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬2件: 42, 43 💬
559CellCept 500 mg----1件: 11 💬
560CellCept 500 mg comprimidos recubiertos----1件: 35 💬
561CellCept 500 mg film-coated tablets----1件: 11 💬
562CellCept 500 mg tablets----1件: 11 💬
563CELLCEPT®----1件: 35 💬
564Cellcept® in autoimmune bullous dermatoses----2件: 35, 162 💬
565CellCept®500 mg comprimidos----1件: 35 💬
566CellCept®500 mg tablets----1件: 11 💬
567Cellular therapy with EBV specific autologous CTL infusion----1件: 13 💬
568Cellule CD34+ autologhe trasdotte con IDUA LV codificante per il cDNA dell'alfa-L-iduronidasi----1件: 19 💬
569Cellule mesenchimali stromali di origine cordonale (CB-MSC) per uso allogenico)----1件: 222 💬
570Cellulose----1件: 84 💬
571Cellulose acetate with petrolatum2件: Acetate,
Petrolatum		2件: Petrolatum, white ,
Petrolatum 💬 		--2件: 35, 162 💬
572Cellvizio 100 Series System with Confocal Miniprobes----1件: 215 💬
573Celulas hepatocitos troncales adultas alogenicas de higado expandidas----1件: 251 💬
574Celulas madre mesenquimales troncales adultas alogenicas de médula ósea no expandida----1件: 274 💬
575Cemdisiran1件: Cemdisiran---6件: 11, 15, 62, 66, 109, 223 💬
576Cendakimab1件: Cendakimab1件: Cendakimab 💬 1件: IL13 💬 8件: Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬1件: 98 💬
577Cenegermin1件: Cenegermin1件: Cenegermin 💬 1件: NGFR 💬 9件: Apoptosis - multiple species, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Transcriptional misregulation in cancer, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬1件: 53 💬
578Cenerimod1件: Cenerimod1件: Cenerimod 💬 1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 49 💬
579Cenerimod 0.5 mg1件: Cenerimod1件: Cenerimod 💬 1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 49 💬
580Cenerimod 1 mg1件: Cenerimod1件: Cenerimod 💬 1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 49 💬
581Cenerimod 2 mg1件: Cenerimod1件: Cenerimod 💬 1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 49 💬
582Cenerimod 2 mg (ex-4 mg)1件: Cenerimod1件: Cenerimod 💬 1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 49 💬
583Cenerimod 4 mg1件: Cenerimod1件: Cenerimod 💬 1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 49 💬
584Cenicriviroc1件: Cenicriviroc2件: Cenicriviroc ,
Cenicriviroc mesylate 💬 		2件: CCR2,
CCR5 💬 		11件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 94 💬
585Cenicriviroc 150 mg1件: Cenicriviroc2件: Cenicriviroc ,
Cenicriviroc mesylate 💬 		2件: CCR2,
CCR5 💬 		11件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 94 💬
586Cenplacel-L1件: Cenplacel-L1件: Cenplacel-L 💬 --1件: 84 💬
587CENSAVUDINE1件: Censavudine1件: Censavudine 💬 --3件: 2, 127, 325 💬
588Centerpiece titanium plate1件: Titanium---1件: 70 💬
589Central venous line placement----1件: 215 💬
590Centricyte 1000----2件: 85, 229 💬
591CEP-13471件: CEP-1347---1件: 6 💬
592CEP-1347 10mg1件: CEP-1347---1件: 6 💬
593CEP-1347 50mg1件: CEP-1347---1件: 6 💬
594CEP-33457----1件: 49 💬
595CEP1347----1件: 6 💬
596CEP1347 25mg----1件: 6 💬
597Cephalexin1件: Cephalexin2件: Cefalexin ,
Cephalexin 💬 		--1件: 299 💬
598Cepharanthine1件: Cepharanthine1件: Cepharanthine 💬 --1件: 53 💬
599CER-0011件: CER-001---1件: 79 💬
600Ceralifimod1件: Ceralifimod---1件: 13 💬
601Ceralifmod----1件: 13 💬
602Cerazette----1件: 230 💬
603CERC-006----1件: 278 💬
604Cerdelga----1件: 19 💬
605CERE-1201件: CERE-120---1件: 6 💬
606CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN])1件: CERE-120---1件: 6 💬
607CERE-120: Adeno-Associated Virus Delivery of Neurturin1件: CERE-120---1件: 6 💬
608Cerebral Dopamine Neurotrophic Factor1件: Dopamine2件: Dopamine hydrochloride ,
Dopamine 💬 		5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
609Cerebro-spinal fluid----1件: 13 💬
610Cerebrolysin1件: Cerebrolysin---1件: 124 💬
611CEREDASE™----1件: 19 💬
612Ceretec----1件: 6 💬
613CERETEC (TM) Estabilizado----1件: 6 💬
614CEREZYME----1件: 19 💬
615Cerezyme (imiglucerase for injection)1件: Imiglucerase2件: Alglucerase ,
Imiglucerase 💬 		1件: GBA1 💬 4件: Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
616Cerezyme 400 Units Powder for concentrate for solution for infusion----1件: 19 💬
617Cerezyme 400 Units Powder for concentrate for solution for infusionPharmaceutical Form: Powder for concentrate for solution for infusionINN or Proposed INN: ImigluceraseCAS Number: 154248-97-2Concentration unit: U unit(s)Concentration type: equalConcentration number: 400-Pharmaceutical form of the placebo: Solution for infusionRoute of administration of the placebo: Intravenous use----1件: 19 💬
618Cerezyme 400 Unità Polvere per concentrato per soluzione per infusione----1件: 19 💬
619Cerezyme®----1件: 19 💬
620Cerezyme® / Imiglucerase1件: Imiglucerase2件: Alglucerase ,
Imiglucerase 💬 		1件: GBA1 💬 4件: Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
621Cerliponase Alfa1件: Cerliponase alfa1件: Cerliponase alfa 💬 1件: TPP1 💬 1件: Lysosome biogenesis 💬1件: 19 💬
622Certican----3件: 67, 96, 228 💬
623Certican 0,5----1件: 228 💬
624Certican 0,5 mg Tabletten----1件: 228 💬
625Certican 0,75mg----1件: 228 💬
626Certican 0,75mg Tabletten----1件: 228 💬
627Certican 1 mg tablets----1件: 158 💬
628Certican Tabletten----1件: 67 💬
629Certolizumab----6件: 46, 48, 49, 96, 270, 271 💬
630Certolizumab Pegol1件: Certolizumab pegol1件: Certolizumab pegol 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
631Certolizumab pegol (CDP870)1件: Certolizumab pegol1件: Certolizumab pegol 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 96 💬
632Certolizumab pegol (CDP870, CZP)1件: Certolizumab pegol1件: Certolizumab pegol 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
633Certolizumab pegol (CDP870, tradename Cimzia)1件: Certolizumab pegol1件: Certolizumab pegol 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
634Certolizumab pegol (CDP870, tradename Cimzia)(prefilled syringes at the dose of 200mg)1件: Certolizumab pegol1件: Certolizumab pegol 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
635Certolizumab Pegol (CZP)1件: Certolizumab pegol1件: Certolizumab pegol 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬4件: 46, 96, 107, 271 💬
636Certolizumab Pegol (CZP) 200 mg1件: Certolizumab pegol1件: Certolizumab pegol 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
637Certolizumab Pegol (CZP) 400 mg1件: Certolizumab pegol1件: Certolizumab pegol 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
638Certolizumab pegol (rINN)1件: Certolizumab pegol1件: Certolizumab pegol 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
639Certolizumab Pegol + Methotrexate (MTX)2件: Certolizumab pegol,
Methotrexate		3件: Methotrexate ,
Methotrexate sodium ,
Certolizumab pegol 💬 		3件: DHFR,
DHFR2,
TNF 💬 		69件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Folate transport and metabolism, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
640Certolizumab pegol / CIMZIA1件: Certolizumab pegol1件: Certolizumab pegol 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
641Certolizumab Pegol /Cimzia1件: Certolizumab pegol1件: Certolizumab pegol 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
642Certolizumab Pegol 200 MG/ML [Cimzia]1件: Certolizumab pegol1件: Certolizumab pegol 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
643Certolizumab pegol 400 mg1件: Certolizumab pegol1件: Certolizumab pegol 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
644CertolizumabPegol injection----1件: 46 💬
645CERTOLUZIMAB PEGOL----1件: 46 💬
646Cervarix suspensie voor injectie----3件: 49, 50, 107 💬
647Cervical interbody fusion----1件: 70 💬
648Cervical spinal cord and brain MRI----1件: 2 💬
649Cesamet™ (nabilone)1件: Nabilone1件: Nabilone 💬 2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
650Ceterizine----1件: 13 💬
651Cetirizina1件: Cetirizine2件: Cetirizine hydrochloride ,
Cetirizine 💬 		1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬3件: 13, 300, 309 💬
652CETIRIZINA DICLORIDRATO----1件: 28 💬
653Cetirizina Mylan Generics1件: Cetirizine2件: Cetirizine hydrochloride ,
Cetirizine 💬 		1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 13 💬
654CETIRIZINA SANDOZ - 10 MG COMPRESSE RIVESTITE CON FILM 20 COMPRESSE IN BLISTER PVC/ALU----1件: 300 💬
655Cetirizine1件: Cetirizine2件: Cetirizine hydrochloride ,
Cetirizine 💬 		1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬3件: 13, 19, 35 💬
656CETIRIZINE HYDROCHLORIDE1件: Cetirizine2件: Cetirizine hydrochloride ,
Cetirizine 💬 		1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 13 💬
657Cetrizine----1件: 13 💬
658Cetrorelix1件: Cetrorelix2件: Cetrorelix acetate ,
Cetrorelix 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 46 💬
659Cetuximab1件: Cetuximab1件: Cetuximab 💬 1件: EGFR 💬 49件: Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease, Cushing syndrome, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Virion - Hepatitis viruses 💬5件: 34, 51, 86, 89, 331 💬
660Cevidoplenib1件: Cevidoplenib---2件: 46, 63 💬
661Cevimeline1件: Cevimeline2件: Cevimeline hydrochloride ,
Cevimeline 💬 		1件: CHRM3 💬 12件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬1件: 53 💬
662Cevostamab1件: Cevostamab1件: Cevostamab 💬 1件: CD3E 💬 11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬1件: 49 💬
663CF patients with a G551D mutation and treated with Ivacaftor1件: Ivacaftor1件: Ivacaftor 💬 1件: CFTR 💬 9件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
664CF-CB-MSC----1件: 222 💬
665CF101----1件: 46 💬
666CF101 1 mg----1件: 46 💬
667CF101 2 mg----1件: 46 💬
668CFTR Modulators----1件: 299 💬
669CFTR potentiator----1件: 299 💬
670CFZ533----4件: 11, 46, 49, 53 💬
671CFZ533 active - Cohort 1----1件: 53 💬
672CFZ533 active - Cohort 2----1件: 53 💬
673CFZ533 active - Cohort 3----1件: 53 💬
674CFZ533 active -Cohort 3----1件: 53 💬
675CG-BM1----1件: 271 💬
676CGM/CKM----1件: 67 💬
677CGMP protein----1件: 97 💬
678CGP 77116----1件: 13 💬
679CH-1504----1件: 46 💬
680CH-4051----1件: 46 💬
681Ch11-1F4 (NSC-711516)----1件: 28 💬
682ChAdOx2 HAV----1件: 96 💬
683Chamomile1件: Chamomile1件: German chamomile flower 💬 --1件: 6 💬
684Champix----1件: 6 💬
685Characterization of carotenoid status and plasma levels of oxidative stress markers in patients (case group only)----1件: 264 💬
686Charcoal----1件: 13 💬
687Chelation----1件: 60 💬
688Chemical name: [R-(R*, R*)]-2-(4-fluorophenyl)-beta, ?-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenyl----1件: 79 💬
689Chemical name: [R-(R*, R*)]-2-(4-fluorophenyl)-ß, ?-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenyl----1件: 79 💬
690CHEMICALLY MODIFIED RECOMBINANT HUMAN SULFAMIDASE----1件: 19 💬
691Chemotherapy----3件: 28, 60, 285 💬
692Chemotherapy Agents----1件: 51 💬
693Chemotherapy, intrathecal chemotherapy, steroid therapy----1件: 65 💬
694Chemotherapy: cyclophosphamide (CYC)1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--1件: 13 💬
695Chemotherapy: fludarabine (FLU)1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
696Chenodeoxycholic acid1件: Chenodeoxycholic acid1件: Chenodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬5件: 20, 86, 96, 234, 263 💬
697Chenodeoxycholic acid leadiant1件: Chenodeoxycholic acid1件: Chenodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 263 💬
698Chenodiol1件: Chenodeoxycholic acid1件: Chenodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 96 💬
699Chenofalk----1件: 96 💬
700Cherry1件: Cherry---1件: 97 💬
701Chest X-ray----1件: 215 💬
702CHF 6333----1件: 299 💬
703CHF10067----1件: 85 💬
704CHF10067 high dose -- 3000mg (Cohort C)----1件: 85 💬
705CHF10067 intermediate dose -- 2000mg (Cohort B)----1件: 85 💬
706CHF10067 starting dose -- 1000mg (Cohort A)----1件: 85 💬
707CHF6333----1件: 299 💬
708CHF6333 (Part 1 - SAD)----1件: 299 💬
709CHF6333 (Part 2 - MAD)----1件: 299 💬
710CHF6657----1件: 19 💬
711Chicken1件: Chicken---1件: 46 💬
712Chicken type II collagen1件: Chicken---1件: 46 💬
713Chidamide----1件: 63 💬
714CHIMERIC FIBRIL-REACTIVE IGG1K MONOCLONAL ANTIBODY 11-1F4----1件: 28 💬
715Chimeric Fibril-Reactive Monoclonal Anti-body 11-1F4----1件: 28 💬
716Chimeric Human-Murine IgG1 ----1件: 46 💬
717Chimeric human/mouse anti-CD-20 monoclonal antibody----1件: 46 💬
718Chimeric IgG1 monoclonal antibody----1件: 96 💬
719Chimeric monoclonal antibody, IgG4 subtype----2件: 43, 44 💬
720Chimeric murine human anti-IL-6 monoclonal antibody----1件: 331 💬
721Chinese Herb Prescription Granule plus prednisone1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
722Chinese herbal concoction twice a day for 6 months----1件: 60 💬
723Chinese herbal medicine treatment----1件: 6 💬
724Chinese herbal tea TBDESJS----1件: 53 💬
725Chinese herbs based on syndrome differentiation----1件: 224 💬
726Chinese medicine WT----1件: 18 💬
727Chlorambucil1件: Chlorambucil1件: Chlorambucil 💬 --2件: 222, 223 💬
728Chlorhexidine1件: Chlorhexidine4件: Chlorhexidine gluconate ,
Chlorhexidine hydrochloride ,
Chlorhexidine ,
Chlorhexidine acetate 💬 		--2件: 86, 299 💬
729Chlorhexidine Gluconate1件: Chlorhexidine4件: Chlorhexidine gluconate ,
Chlorhexidine hydrochloride ,
Chlorhexidine ,
Chlorhexidine acetate 💬 		--1件: 299 💬
730Chlorhexidine gluconate oral rinse1件: Chlorhexidine4件: Chlorhexidine gluconate ,
Chlorhexidine hydrochloride ,
Chlorhexidine ,
Chlorhexidine acetate 💬 		--1件: 299 💬
731Chloride ion1件: Chloride ion---1件: 299 💬
732Chlorogenic Acid1件: Chlorogenic Acid---1件: 97 💬
733Chloroquine1件: Chloroquine4件: Chloroquine phosphate ,
Chloroquine ,
Chloroquine hydrochloride ,
Chloroquine sulfate 💬 		--3件: 46, 49, 95 💬
734Chloroquine diphosphate1件: Chloroquine4件: Chloroquine phosphate ,
Chloroquine ,
Chloroquine hydrochloride ,
Chloroquine sulfate 💬 		--1件: 95 💬
735Chloroquine diphosphate 250mg1件: Chloroquine4件: Chloroquine phosphate ,
Chloroquine ,
Chloroquine hydrochloride ,
Chloroquine sulfate 💬 		--1件: 95 💬
736Chlorothiazide1件: Chlorothiazide2件: Chlorothiazide ,
Chlorothiazide sodium 💬 		1件: SLC12A3 💬 1件: Parathyroid hormone synthesis, secretion and action 💬1件: 225 💬
737Chlorpromazine1件: Chlorpromazine2件: Chlorpromazine ,
Chlorpromazine hydrochloride 💬 		13件: ADRA2A,
ADRA2B,
ADRA2C,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5,
DRD2,
HRH1,
HTR2A,
HTR2B,
HTR2C 💬 		24件: Alcoholism, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Cocaine addiction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Hormone signaling, Inflammatory mediator regulation of TRP channels, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Regulation of actin cytoskeleton, Salivary secretion, Serotonergic synapse, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 120, 254 💬
738Chlorpromazine Hydrochloride1件: Chlorpromazine2件: Chlorpromazine ,
Chlorpromazine hydrochloride 💬 		13件: ADRA2A,
ADRA2B,
ADRA2C,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5,
DRD2,
HRH1,
HTR2A,
HTR2B,
HTR2C 💬 		24件: Alcoholism, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Cocaine addiction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Hormone signaling, Inflammatory mediator regulation of TRP channels, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Regulation of actin cytoskeleton, Salivary secretion, Serotonergic synapse, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 254 💬
739CHLORURE DE SODIUM----1件: 96 💬
740Chocolate----1件: 6 💬
741CHOLECALCIFEROL1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬10件: 13, 19, 34, 46, 49, 96, 97, 222, 298, 299 💬
742Cholecalciferol (Vitamin D3)1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬2件: 13, 299 💬
743Cholecalciferol (vitaminD3)1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299 💬
744Cholecalciferol 10,000 IU1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 96 💬
745Cholecalciferol 400 IU1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 96 💬
746Cholecalciferol and C. Xanthorrhiza1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 49 💬
747CHOLECALCIFEROL CONCENTRATE1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 96 💬
748CHOLECALCIFEROL CONCENTRATE (WATER-DISPERSIBLE FORM)2件: Cholecalciferol,
Water		2件: Water ,
Cholecalciferol 💬 		1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 96 💬
749Cholecalciferol Pill1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299 💬
750Cholecalciferol vial (100 000 UI)1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 222 💬
751Cholecalciferol, Vitamin D31件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 13 💬
752Cholestagel----2件: 79, 96 💬
753Cholesterol1件: Cholesterol1件: Cholesterol 💬 --10件: 8, 19, 71, 79, 90, 160, 222, 259, 261, 310 💬
754Cholesterol supplementation1件: Cholesterol1件: Cholesterol 💬 --1件: 310 💬
755Cholesterol Suspension1件: Cholesterol1件: Cholesterol 💬 --1件: 310 💬
756Cholestyramine1件: Cholestyramine1件: Cholestyramine resin 💬 --2件: 13, 79 💬
757Cholic Acid1件: Cholic Acid1件: Cholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬4件: 20, 234, 265, 310 💬
758Cholic Acids----2件: 20, 234 💬
759Choline1件: Choline1件: Choline 💬 --4件: 93, 171, 193, 299 💬
760Choline Chloride1件: Choline1件: Choline 💬 --1件: 299 💬
761Choline supplementation1件: Choline1件: Choline 💬 --1件: 299 💬
762Chondroitin sulfate1件: Chondroitin sulfate1件: Chondroitin sulfate A 💬 --2件: 96, 226 💬
763Chong Kun Dang Tofacitinib Tablet1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
764CHOP-daclizumab1件: Daclizumab1件: Daclizumab 💬 1件: IL2RA 💬 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 26 💬
765CHR-1103 / GBR500----1件: 13 💬
766Chromium1件: Chromium---1件: 46 💬
767Chronic Antioxidant----1件: 299 💬
768Chronic Corticosteroid Therapy----1件: 113 💬
769Chronic- PF-06480605 150 mg SC Q4W----1件: 97 💬
770Chronic- PF-06480605 450 mg SC Q4W----1件: 97 💬
771Chronic- PF-06480605 50 mg SC Q4W----1件: 97 💬
772Chronocort----1件: 81 💬
773Chronocort 10mg----1件: 81 💬
774Chronocort 5mg----1件: 81 💬
775Chronocort®----1件: 81 💬
776Chronocort® 10 mg----1件: 81 💬
777Chronocort® 20 mg----1件: 81 💬
778Chronocort® 5 mg----1件: 81 💬
779CHS-0214----1件: 46 💬
780Chuna manipulation----1件: 70 💬
781Chuna manual medicine----1件: 70 💬
782CHX A-DTPA anti-CD66 antibody----1件: 28 💬
783CHX-A-DTPA-Anti-CD66----1件: 28 💬
784CI-984----1件: 75 💬
785CI-984, 17AA70, PD 132301-2----1件: 81 💬
786Cialis----2件: 51, 86 💬
787CIALIS - 20 MG 2 COMPRESSE RIVESTITE CON FILM IN BLISTER USO ORALE----2件: 75, 77 💬
788Cialis 10 mg film-coated tablets----2件: 86, 113 💬
789Cialis 2.5 mg film-coated tablets----2件: 86, 113 💬
790CIALIS 20 mg comprimidos recubiertos con película----1件: 86 💬
791Cialis 20 mg film-coated tablets----2件: 86, 113 💬
792Cialis 5 mg film-coated tablets----2件: 86, 113 💬
793CIANOCOBALAMINA FU DC.IT----1件: 13 💬
794CIC----1件: 118 💬
795CIC using LoFric Primo----1件: 13 💬
796Ciclesonide1件: Ciclesonide1件: Ciclesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 84 💬
797Cicletanine1件: Cicletanine2件: Cicletanine ,
Cicletanine hydrochloride 💬 		--1件: 86 💬
798Cicletanine hydrochloride1件: Cicletanine2件: Cicletanine ,
Cicletanine hydrochloride 💬 		--1件: 86 💬
799Ciclofosfamida----1件: 222 💬
800CICLOFOSFAMIDE1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--2件: 49, 51 💬
801Ciclopirox1件: Ciclopirox2件: Ciclopirox olamine ,
Ciclopirox 💬 		--1件: 254 💬
802Ciclosporin1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬10件: 26, 46, 49, 50, 53, 60, 97, 226, 228, 269 💬
803Ciclosporin (Ciclosporinium)1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
804CICLOSPORIN A1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
805Ciclosporin Soft Capsule----1件: 60 💬
806Ciclosporin soft capsules----1件: 222 💬
807CICLOSPORINA----3件: 49, 60, 97 💬
808Ciclosporina / Ciclosporin----1件: 228 💬
809Ciclosporina A Liposomica Aerolised Liposomal Ciclosporin A----1件: 228 💬
810Ciclosporina Generis 100 mg Cápsulas moles----1件: 222 💬
811Ciclosporina/ Ciclosporin----1件: 228 💬
812Ciclosporine----1件: 60 💬
813Ciclosporine A----1件: 228 💬
814Ciclosporine, Ciclosporina----1件: 228 💬
815CID-103----1件: 63 💬
816Cidofovir1件: Cidofovir1件: Cidofovir 💬 --1件: 25 💬
817CIGB-814 (multiple-dose group)----1件: 46 💬
818CIGB-814 (single-dose group)----1件: 46 💬
819CIK cells----1件: 118 💬
820Ciklosporin----1件: 226 💬
821CILASTATIN1件: Cilastatin2件: Cilastatin sodium ,
Cilastatin 💬 		--2件: 60, 299 💬
822Cilazapril1件: Cilazapril2件: Cilazapril ,
Cilazapril 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 66 💬
823Ciliary Neurotrophic Factor Implant NT-501----1件: 90 💬
824Cilnidipine1件: Cilnidipine1件: Cilnidipine 💬 5件: CACNA1B,
CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬 		41件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Morphine addiction, Nicotine addiction, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 67 💬
825CILO----1件: 94 💬
826Cilofexor1件: Cilofexor---2件: 93, 94 💬
827Cilostazol1件: Cilostazol1件: Cilostazol 💬 3件: PDE3A,
PDE3B,
TBXA2R 💬 		13件: Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬7件: 6, 13, 46, 48, 51, 70, 124 💬
828Cilostazol 100 MG1件: Cilostazol1件: Cilostazol 💬 3件: PDE3A,
PDE3B,
TBXA2R 💬 		13件: Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬
829Ciltacabtagene Autoleucel1件: Ciltacabtagene autoleucel1件: Ciltacabtagene autoleucel 💬 2件: CD38,
TNFRSF17 💬 		8件: Calcium signaling pathway, Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬1件: 28 💬
830Cimetidine1件: Cimetidine2件: Cimetidine ,
Cimetidine hydrochloride 💬 		1件: HRH2 💬 4件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬2件: 2, 254 💬
831Cimetidine plus Dexpramipexole2件: Cimetidine,
Dexpramipexole		4件: Cimetidine ,
Cimetidine hydrochloride ,
Dexpramipexole ,
Dexpramipexole dihydrochloride 💬 		6件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5,
HRH2 💬 		14件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 2 💬
832CIMZIA----7件: 46, 48, 49, 96, 97, 107, 271 💬
833CIMZIA (Certolizumab Pegol)1件: Certolizumab pegol1件: Certolizumab pegol 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
834CIMZIA - 200MG-SOLUZIONE INIETTABILE-USO SOTTOCUTANEO-SIRINGA PRERIEMPITA(VETRO) 1ML 6(3X2) SIRINGHE PRERIEMPITE+6(3X2) SALVIETTINE IMBEVUTE DI----1件: 46 💬
835CIMZIA - 200MG-SOLUZIONE INIETTABILE-USO SOTTOCUTANEO-SIRINGA PRERIEMPITA(VETRO) 1ML 6(3X2) SIRINGHE PRERIEMPITE+6(3X2) SALVIETTINE IMBEVUTE DI ALCOOL----1件: 46 💬
836Cimzia 200 mg injeksjonsvæske, oppløsning----1件: 46 💬
837Cimzia 200 mg solution for injection----3件: 46, 96, 271 💬
838CIMZIA certolizumab pegol 200 mg/ml solution for injection1件: Certolizumab pegol1件: Certolizumab pegol 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
839Cimzia®----2件: 46, 271 💬
840Cinacalcet1件: Cinacalcet2件: Cinacalcet ,
Cinacalcet hydrochloride 💬 		1件: CASR 💬 2件: NOD-like receptor signaling pathway, Parathyroid hormone synthesis, secretion and action 💬1件: 238 💬
841Cinnamyl alcohol1件: Cinnamyl alcohol---1件: 279 💬
842CINRYZE----1件: 65 💬
843CINRYZE 1000----1件: 65 💬
844CINRYZE 1000 U----1件: 65 💬
845CINRYZE 500----1件: 65 💬
846CINRYZE 500 U----1件: 65 💬
847CINRYZE with rHuPH20----1件: 65 💬
848CINRYZE®----1件: 65 💬
849CINRYZE® (C1 esterase inhibitor [human])----1件: 61 💬
850CION-08 Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 60-Product Name: bempedoic acidPharmaceutical Form: Suspension for oral suspensionINN or Proposed INN: Bempedoic acidCAS Number: 738606-46-7 Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 20-----1件: 79 💬
851CION-08 Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 90-Trade Name: Nilemdo Product Name: bempedoic acidPharmaceutical Form: TabletINN or Proposed INN: Bempedoic acidCAS Number: 738606-46-7 Current Sponsor code: ETC-1002----1件: 79 💬
852Cipaglucosidase Alfa1件: Cipaglucosidase alfa1件: Cipaglucosidase alfa 💬 1件: GAA 💬 3件: Galactose metabolism, Lysosome biogenesis, Starch and sucrose metabolism 💬1件: 256 💬
853Cipaglucosidasi alfa----1件: 256 💬
854CIPRALEX----1件: 6 💬
855Cipro (Ciprofloxacin, BAYQ3939)1件: Ciprofloxacin3件: Ciprofloxacin ,
Ciprofloxacin hydrochloride ,
Ciprofloxacin lactate 💬 		--1件: 299 💬
856Cipro Inhale----1件: 299 💬
857Cipro, Ciprofloxacin1件: Ciprofloxacin3件: Ciprofloxacin ,
Ciprofloxacin hydrochloride ,
Ciprofloxacin lactate 💬 		--1件: 2 💬
858Ciprofloxacin1件: Ciprofloxacin3件: Ciprofloxacin ,
Ciprofloxacin hydrochloride ,
Ciprofloxacin lactate 💬 		--6件: 2, 46, 60, 96, 97, 299 💬
859Ciprofloxacin (BAYQ3939) dry powder for inhalation1件: Ciprofloxacin3件: Ciprofloxacin ,
Ciprofloxacin hydrochloride ,
Ciprofloxacin lactate 💬 		--1件: 299 💬
860Ciprofloxacin (Cipro Inhale, BAYQ3939)1件: Ciprofloxacin3件: Ciprofloxacin ,
Ciprofloxacin hydrochloride ,
Ciprofloxacin lactate 💬 		--1件: 299 💬
861Ciprofloxacin (Cipro, BAYQ3939)1件: Ciprofloxacin3件: Ciprofloxacin ,
Ciprofloxacin hydrochloride ,
Ciprofloxacin lactate 💬 		--1件: 299 💬
862Ciprofloxacin (ciproxin)1件: Ciprofloxacin3件: Ciprofloxacin ,
Ciprofloxacin hydrochloride ,
Ciprofloxacin lactate 💬 		--1件: 299 💬
863Ciprofloxacin dispersion for inhalation1件: Ciprofloxacin3件: Ciprofloxacin ,
Ciprofloxacin hydrochloride ,
Ciprofloxacin lactate 💬 		--1件: 299 💬
864Ciprofloxacin DPI1件: Ciprofloxacin3件: Ciprofloxacin ,
Ciprofloxacin hydrochloride ,
Ciprofloxacin lactate 💬 		--1件: 299 💬
865Ciprofloxacin DPI (BAYQ3939)1件: Ciprofloxacin3件: Ciprofloxacin ,
Ciprofloxacin hydrochloride ,
Ciprofloxacin lactate 💬 		--1件: 299 💬
866Ciprofloxacin for Inhalation1件: Ciprofloxacin3件: Ciprofloxacin ,
Ciprofloxacin hydrochloride ,
Ciprofloxacin lactate 💬 		--1件: 299 💬
867Ciprofloxacin hydrochloride1件: Ciprofloxacin3件: Ciprofloxacin ,
Ciprofloxacin hydrochloride ,
Ciprofloxacin lactate 💬 		--2件: 96, 299 💬
868CIPROFLOXACIN HYDROCHLORIDE MONOHYDRATE1件: Ciprofloxacin3件: Ciprofloxacin ,
Ciprofloxacin hydrochloride ,
Ciprofloxacin lactate 💬 		--1件: 299 💬
869Ciprofloxacin Inhale1件: Ciprofloxacin3件: Ciprofloxacin ,
Ciprofloxacin hydrochloride ,
Ciprofloxacin lactate 💬 		--1件: 299 💬
870Ciprofloxacina----1件: 299 💬
871CIPROFLOXACINA CLORIDRATO----2件: 2, 299 💬
872Ciproxin----1件: 299 💬
873CIPROXIN - 500 MG COMPRESSE RIVESTITE 14 COMPRESSE----1件: 299 💬
874Ciproxin Suspension----1件: 299 💬
875CIPROXIN*6CPR RIV 500MG----1件: 299 💬
876Circadian rhythm measurement----1件: 106 💬
877Circadin----1件: 13 💬
878Circadin ( INN= Melatonin)1件: Melatonin1件: Melatonin 💬 2件: MTNR1A,
MTNR1B 💬 		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 13 💬
879Circadin 2 mg----1件: 90 💬
880CIRCADIN 2 mg comprimidos de liberación prolongada----1件: 90 💬
881Circadin®----1件: 6 💬
882Cis-4-Hydroxy-L-Proline1件: Proline1件: Proline 💬 --1件: 94 💬
883CISAPRIDE1件: Cisapride2件: Cisapride ,
Cisapride 💬 		3件: HTR2A,
HTR3A,
HTR4 💬 		8件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
884Cisplatin1件: Cisplatin1件: Cisplatin 💬 --1件: 28 💬
885Cistanche Total Glycosides----1件: 2 💬
886CIT-013 high dose----1件: 46 💬
887CIT-013 low dose----1件: 46 💬
888CIT-013 medium dose----1件: 46 💬
889Citalopram1件: Citalopram2件: Citalopram hydrobromide ,
Citalopram 💬 		1件: SLC6A4 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬7件: 6, 8, 13, 18, 46, 98, 127 💬
890Citalopram 20mg1件: Citalopram2件: Citalopram hydrobromide ,
Citalopram 💬 		1件: SLC6A4 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 6 💬
891CITARABINA----1件: 13 💬
892CITICOLIN*1G/4ML IM IV 5 F----1件: 6 💬
893Citicolina 1000 mg/die----1件: 6 💬
894CITICOLINA SODICA----1件: 6 💬
895CITOCHINE ED IMMUNOMODULATORI----1件: 13 💬
896Citocoline----1件: 205 💬
897Citric acid1件: Citric acid2件: Citric acid, anhydrous ,
Citric acid monohydrate 💬 		--2件: 53, 291 💬
898Citric Acid based Mouthwash1件: Citric acid2件: Citric acid, anhydrous ,
Citric acid monohydrate 💬 		--1件: 53 💬
899Citrulline1件: Citrulline2件: L-Citrulline ,
Citrulline malate 💬 		--3件: 21, 86, 113 💬
900Cizutamig----4件: 11, 46, 49, 97 💬
901CJH1 (CLR4001)----1件: 6 💬
902CJNJ-68150420-ZZZ-G001 (ACT- 064992D)----1件: 86 💬
903CJNJ-68150420-ZZZ-G001 (ACT-064992D)----1件: 86 💬
904CJNJ-68150420-ZZZ-G001(ACT-064992D)----1件: 86 💬
905CK-2017357----1件: 2 💬
906CK-2017357 (Part A)----1件: 2 💬
907CK-2017357 (Part B)----1件: 2 💬
908CK-21271071件: Reldesemtiv1件: Reldesemtiv 💬 3件: TNNC2,
TNNI2,
TNNT3 💬 		3件: Calcium signaling pathway, Cytoskeleton in muscle cells, Motor proteins 💬1件: 2 💬
909CK-3773274----1件: 58 💬
910CK-3773274 (10 - 30 mg)----1件: 58 💬
911CK-3773274 (5 - 15 mg)----1件: 58 💬
912CK-3773274 - Granules in Capsule----1件: 58 💬
913CK-3773274 - Tablets----1件: 58 💬
914CK0801----1件: 60 💬
915CK0803----1件: 2 💬
916CK2017357----1件: 2 💬
917CKD-374 5mg Tab.----1件: 46 💬
918CKD-5041件: CKD-504---1件: 8 💬
919CKD-506----1件: 46 💬
920CLA (Chlorogenic acid)1件: Chlorogenic Acid---1件: 97 💬
921CLADRIBINA1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
922Cladribina oral1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
923CLADRIBINE1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬3件: 11, 13, 94 💬
924Cladribine (MAVENCLAD®)1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
925Cladribine 10 mg oral tablet1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
926Cladribine 3.5 mg/kg1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
927Cladribine 5.25 mg/kg1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
928Cladribine High Dose1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 11 💬
929Cladribine Low Dose1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 11 💬
930Cladribine Oral Tablet1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
931Cladribine Pill1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
932Cladribine Subcutaneous Injection1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
933Cladribine Tablet1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
934Cladribine Tablets1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
935Cladrybine----1件: 11 💬
936CLAIRYG 50 mg/ml----1件: 14 💬
937CLAIRYG 50mg/ml----1件: 14 💬
938Clarithromycin1件: Clarithromycin1件: Clarithromycin 💬 --10件: 6, 46, 63, 84, 96, 97, 222, 223, 228, 299 💬
939Clarithromycin (Not used as of 4/2020)1件: Clarithromycin1件: Clarithromycin 💬 --1件: 6 💬
940Clarithromycin 15 mg/kg/day in 2 divided doses for 14 days.1件: Clarithromycin1件: Clarithromycin 💬 --1件: 63 💬
941Claritromycin----1件: 299 💬
942Claritromycin 500mg film coated tablets----1件: 299 💬
943Clarium 50 mg Retardtabletten----1件: 6 💬
944Clarix Flo----1件: 226 💬
945Clartihromycin, amoxicillin, and omeprazole2件: Amoxicillin,
Omeprazole		6件: Amoxicillin ,
Omeprazole ,
Omeprazole sodium ,
Amoxicillin sodium ,
Omeprazole magnesium ,
Amoxicillin 💬 		2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬1件: 6 💬
946Claseprubart1件: Claseprubart---2件: 11, 14 💬
947Classic DMARDs treatment group----1件: 46 💬
948Classical ketogenic diet----1件: 137 💬
949Clasteon----1件: 274 💬
950ClaversalPharmaceutical Form: Gastro-resistant tabletINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: ClaversalPharmaceutical Form: SuppositoryINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: ClaversalPharmaceutical Form: Rectal foamINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: ColitofalkPharmaceutical Form: Gastro-resistant granules for oral suspension in sachetINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: PentasaPharmaceutical Form: TabletINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: PentasaPharmaceutical Form: SuppositoryINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: PentasaPharmaceutical Form: Granules for oral solution in sachetINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: MezavantPharmaceutical Form: Gastro-resistant tabletINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: Mesalazine TevaPharmaceutical Form: Gastro-resistant tabletINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: ColitofalkPharmaceutical Form: SuppositoryINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: ColitofalkPharmaceutical Form: Rectal suspensionINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: SalazopyrinePharmaceutical Form: Gastro-resistant tabletINN or Proposed INN: SulfasalazineCAS Number: 599-79-1Trade Name: PentasaPharmaceutical Form: Rectal suspensionINN or Proposed INN: MesalazineCAS Number: 89-57-61件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
951CLAVULANIC ACID1件: Clavulanic acid2件: Clavulanate potassium ,
Clavulanic acid 💬 		--1件: 299 💬
952CLAZAKIZUMAB1件: Clazakizumab1件: Clazakizumab 💬 --1件: 46 💬
953CLBS121件: CLBS12---1件: 47 💬
954CLE----1件: 6 💬
955Clemastine1件: Clemastine2件: Clemastine fumarate ,
Clemastine 💬 		1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬2件: 13, 179 💬
956CLEMASTINE FUMARATE1件: Clemastine2件: Clemastine fumarate ,
Clemastine 💬 		1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 13 💬
957Clemastine Fumarate Tablets1件: Clemastine2件: Clemastine fumarate ,
Clemastine 💬 		1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 179 💬
958Clemastine Milstein 1 mg, tabletten1件: Clemastine2件: Clemastine fumarate ,
Clemastine 💬 		1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 13 💬
959Clemizole1件: Clemizole2件: Clemizole hydrochloride ,
Clemizole 💬 		1件: TRPC5 💬 2件: Axon guidance, GnRH secretion 💬2件: 140, 144 💬
960Clemizole HCl1件: Clemizole2件: Clemizole hydrochloride ,
Clemizole 💬 		1件: TRPC5 💬 2件: Axon guidance, GnRH secretion 💬2件: 140, 144 💬
961CLEMIZOLE HYDROCHLORIDE1件: Clemizole2件: Clemizole hydrochloride ,
Clemizole 💬 		1件: TRPC5 💬 2件: Axon guidance, GnRH secretion 💬1件: 140 💬
962Clenbuterol1件: Clenbuterol2件: Clenbuterol hydrochloride ,
Clenbuterol 💬 		1件: ADRB2 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬6件: 1, 2, 6, 57, 113, 256 💬
963Clenbuterol HCl1件: Clenbuterol2件: Clenbuterol hydrochloride ,
Clenbuterol 💬 		1件: ADRB2 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
964CLENBUTEROL HYDROCHLORIDE1件: Clenbuterol2件: Clenbuterol hydrochloride ,
Clenbuterol 💬 		1件: ADRB2 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
965CLENBUTEROLO----1件: 1 💬
966Clervonafusp alfa1件: Clervonafusp alfa1件: Clervonafusp alfa 💬 2件: GAA,
SLC29A2 💬 		4件: Alcoholism, Galactose metabolism, Lysosome biogenesis, Starch and sucrose metabolism 💬1件: 309 💬
967Clexane----2件: 223, 327 💬
968Clexane (40 mg)----1件: 223 💬
969Clexane/Lovenox----1件: 327 💬
970Clindamycin1件: Clindamycin4件: Clindamycin ,
Clindamycin phosphate ,
Clindamycin palmitate hydrochloride ,
Clindamycin hydrochloride 💬 		--2件: 46, 299 💬
971Clinical DBS Setting----1件: 6 💬
972Clinically diagnosed AA patients are divided into HLA-matched HSCT group and umbilical cord blood-supported haplo-HSCT group.----1件: 60 💬
973Clinican CBD 10% oil----1件: 13 💬
974CliniMACS----2件: 60, 65 💬
975CliniMACS device----2件: 60, 285 💬
976CliniMACS Prodigy System----1件: 285 💬
977CliniMACS® TCR a/beta Reagent Kit and CliniMACS® CD19 System----3件: 19, 96, 222 💬
978CliniMACS® TCR a/ß Reagent Kit and CliniMACS® CD19 System----3件: 19, 96, 222 💬
979Clipper----1件: 97 💬
980Clipper 30 cpr 5mg R.M.----1件: 97 💬
981CLIPPER*30CPR 5MG R.M.----1件: 97 💬
982CLN-978----3件: 46, 49, 53 💬
983Clobazam1件: Clobazam1件: Clobazam 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		9件: Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬2件: 140, 144 💬
984Clobazam High Dose1件: Clobazam1件: Clobazam 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		9件: Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 144 💬
985Clobazam Low Dose1件: Clobazam1件: Clobazam 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		9件: Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 144 💬
986Clobazam Medium Dose1件: Clobazam1件: Clobazam 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		9件: Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 144 💬
987Clobazam PhEur1件: Clobazam1件: Clobazam 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		9件: Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 144 💬
988Clobazam Tablets1件: Clobazam1件: Clobazam 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		9件: Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 144 💬
989Clobazam Tablets 10mg1件: Clobazam1件: Clobazam 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		9件: Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 144 💬
990Clobazam Tablets 20mg1件: Clobazam1件: Clobazam 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		9件: Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 144 💬
991Clobazam Tablets 5mg1件: Clobazam1件: Clobazam 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		9件: Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 144 💬
992Clobetasol1件: Clobetasol1件: Clobetasol 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬5件: 35, 39, 46, 51, 162 💬
993Clobetasol 0.05% ointment1件: Clobetasol1件: Clobetasol 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 39 💬
994Clobetasol 0.05% Topical Ointment1件: Clobetasol1件: Clobetasol 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 162 💬
995Clobetasol propionate2件: Clobetasol,
Clobetasol propionate		2件: Clobetasol propionate ,
Clobetasol 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬3件: 35, 46, 162 💬
996Clobetasol propionate + Methotrexate3件: Clobetasol,
Clobetasol propionate,
Methotrexate		4件: Methotrexate ,
Clobetasol propionate ,
Methotrexate sodium ,
Clobetasol 💬 		3件: DHFR,
DHFR2,
NR3C1 💬 		4件: Folate biosynthesis, Folate transport and metabolism, Neuroactive ligand-receptor interaction, One carbon pool by folate 💬1件: 162 💬
997Clobetasol propionate 0.05% Mouthwash2件: Clobetasol,
Clobetasol propionate		2件: Clobetasol propionate ,
Clobetasol 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 35 💬
998Clobetasol propionate 0.05% mouthwash + photobiomodulation2件: Clobetasol,
Clobetasol propionate		2件: Clobetasol propionate ,
Clobetasol 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 35 💬
999Clobetasol propionate alone2件: Clobetasol,
Clobetasol propionate		2件: Clobetasol propionate ,
Clobetasol 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 162 💬
1000Clobetasol Propionate cream treatment2件: Clobetasol,
Clobetasol propionate		2件: Clobetasol propionate ,
Clobetasol 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 162 💬
1001Clobetasolo propionato----1件: 162 💬
1002Clofarabine1件: Clofarabine1件: Clofarabine 💬 3件: POLA1,
POLA2,
RRM1 💬 		5件: DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬9件: 19, 20, 40, 46, 49, 60, 96, 234, 326 💬
1003CLOFAZIMINE1件: Clofazimine1件: Clofazimine 💬 --2件: 96, 299 💬
1004Clomiphene citrate----2件: 74, 77 💬
1005Clonazepam1件: Clonazepam1件: Clonazepam 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		9件: Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 6 💬
1006Clonidine1件: Clonidine2件: Clonidine ,
Clonidine hydrochloride 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬3件: 6, 65, 70 💬
1007Clonidine hydrochloride1件: Clonidine2件: Clonidine ,
Clonidine hydrochloride 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 6 💬
1008Clonidinhydrochlorid----1件: 65 💬
1009Clopidogrel1件: Clopidogrel4件: Clopidogrel bisulfate ,
Clopidogrel ,
Clopidogrel hydrochloride ,
Clopidogrel besilate 💬 		1件: P2RY12 💬 3件: Efferocytosis, Neuroactive ligand signaling, Platelet activation 💬7件: 40, 49, 51, 62, 71, 86, 222 💬
1010Clopidogrel treatment1件: Clopidogrel4件: Clopidogrel bisulfate ,
Clopidogrel ,
Clopidogrel hydrochloride ,
Clopidogrel besilate 💬 		1件: P2RY12 💬 3件: Efferocytosis, Neuroactive ligand signaling, Platelet activation 💬1件: 51 💬
1011CLORAMFENICOLO----1件: 90 💬
1012Cloramfenicolo Fisiopharma----1件: 90 💬
1013CLORAMFENICOLO FISIOPHARMA - 1 G/10 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO ENDOVENOSO 1 FLACONCINO POLVERE + 1 FIALA SOLVENTE DA 10 ML----1件: 90 💬
1014CLORFENAMINA MALEATO----1件: 14 💬
1015Cloruro de Sodio----1件: 228 💬
1016CLORURO DI POTASSIO----1件: 97 💬
1017CLORURO DI SODIO----1件: 97 💬
1018CLORURO SODICO 7%----1件: 299 💬
1019Clostridium botulinum1件: Clostridium botulinum---1件: 13 💬
1020CLOSTRIDIUM BOTULINUM TOXIN TYPE A2件: Botulinum toxin type A,
Clostridium botulinum		4件: Botulinum toxin type A ,
OnabotulinumtoxinA ,
AbobotulinumtoxinA ,
Incobotulinumtoxin A 💬 		1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13 💬
1021Clotrimazole1件: Clotrimazole1件: Clotrimazole 💬 --1件: 97 💬
1022CLOZAPINE1件: Clozapine1件: Clozapine 💬 11件: ADRA2A,
ADRA2B,
ADRA2C,
DRD4,
HTR2A,
HTR2C,
HTR3A,
HTR3B,
HTR3C,
HTR3D,
HTR3E 💬 		10件: Calcium signaling pathway, Dopaminergic synapse, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cGMP-PKG signaling pathway 💬1件: 6 💬
1023CLS12311----1件: 13 💬
1024CLS12311 high----1件: 13 💬
1025CLS12311 low----1件: 13 💬
1026CLS12311 medium----1件: 13 💬
1027CLS12311Pharmaceutical Form: Dispersion for infusionINN or Proposed INN: not applicableCurrent Sponsor code: CLS12311Other descriptive name: Peptid coupled red blood cellsConcentration unit: OtherConcentration type: rangeConcentration number: 2.2E11-3.5E11Pharmaceutical form of the placebo: InfusionRoute of administration of the placebo: Intravenous use----1件: 13 💬
1028CLTX-305----1件: 235 💬
1029CLZ-20021件: CLZ-2002---1件: 10 💬
1030CM-1011件: CM-101---2件: 51, 94 💬
1031CM-336 BCMA/CD3 bispecific antibody----1件: 28 💬
1032CM310----1件: 300 💬
1033CM313----1件: 66 💬
1034CM313 (SC)----1件: 35 💬
1035CM313 injection----3件: 35, 49, 63 💬
1036CM313(SC) injection----1件: 60 💬
1037CM336----1件: 53 💬
1038CM336 (BCMA/CD3 bispecific antibody)----1件: 16 💬
1039CM336 Injection----2件: 61, 63 💬
1040CM338----1件: 66 💬
1041CM355----1件: 49 💬
1042CMAB008----1件: 46 💬
1043CME-LEM4----1件: 117 💬
1044CMK389----1件: 84 💬
1045CMP-CPS-001----1件: 251 💬
1046CMR316----1件: 85 💬
1047CMRI----1件: 77 💬
1048CMS----1件: 299 💬
1049CMS-D017 Capsule----1件: 62 💬
1050CMTS0929----1件: 97 💬
1051CMTX-101----1件: 299 💬
1052CMV IgM, IgG in blood real time PCR for serum CMV DNA .----1件: 97 💬
1053CMV-VST----1件: 65 💬
1054CNCT19 CAR-T cell therapy----1件: 61 💬
1055CNCT19 cell injection----2件: 49, 63 💬
1056CND261----1件: 46 💬
1057CNM-Au81件: CNM-Au8---2件: 2, 13 💬
1058CNMAu8----1件: 2 💬
1059CNP-104----1件: 93 💬
1060CNP-106----1件: 11 💬
1061Cnp-MS-0601----1件: 13 💬
1062CNS10-NPC implantation----1件: 90 💬
1063CNS10-NPC-GDNF----1件: 2 💬
1064CNSA-001----1件: 240 💬
1065CNT-02----1件: 160 💬
1066CNTO 1275----2件: 13, 96 💬
1067CNTO 136----2件: 41, 46 💬
1068CNTO 136 100 mg----1件: 46 💬
1069CNTO 136 25 mg----1件: 46 💬
1070CNTO 136 50 mg----1件: 46 💬
1071CNTO 136 IgG----1件: 46 💬
1072CNTO 148----4件: 46, 84, 97, 271 💬
1073CNTO 148 (Golimumab)1件: Golimumab1件: Golimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 107 💬
1074CNTO 1959----1件: 46 💬
1075CNTO 1959 + MTX (Group 4)----1件: 46 💬
1076CNTO 1959 + MTX (Group 5)----1件: 46 💬
1077CNTO 1959 IgG----1件: 46 💬
1078CNTO 2476----1件: 90 💬
1079CNTO 328----1件: 331 💬
1080CNTO 6785 100 mg----1件: 46 💬
1081CNTO 6785 15 mg----1件: 46 💬
1082CNTO 6785 200 mg----1件: 46 💬
1083CNTO 6785 50 mg----1件: 46 💬
1084CNTO 888 1 mg/kg----1件: 85 💬
1085CNTO 888 15 mg/kg----1件: 85 💬
1086CNTO 888 5 mg/kg----1件: 85 💬
1087CNTO-148----1件: 97 💬
1088CNTO1275----6件: 46, 49, 84, 93, 96, 97 💬
1089CNTO136----1件: 46 💬
1090CNTO148----5件: 46, 84, 96, 97, 107 💬
1091CNTO1959----4件: 37, 41, 96, 97 💬
1092CNTO312----1件: 97 💬
1093CNTO328----1件: 331 💬
1094CNTO6785----1件: 46 💬
1095CNTO888----1件: 85 💬
1096CNTY-101----2件: 49, 51 💬
1097CO-14----1件: 13 💬
1098Co-intervention of Prednisolone wean during open label extension phase1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
1099Co-intervention of Prednisolone wean during randomised controlled phase1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
1100Co-medication: Synthetic DMARDs----1件: 46 💬
1101CO-TRIMOXAZOLE----1件: 85 💬
1102CO2 laser----1件: 51 💬
1103Coagadex(R)----2件: 28, 288 💬
1104Coagulation factor XIII----1件: 288 💬
1105Coamoxiclav----1件: 97 💬
1106Coarse wheat bran2件: Wheat,
Wheat bran		1件: Wheat 💬 --1件: 6 💬
1107Cobalt1件: Cobalt---1件: 46 💬
1108Cobalt™ Bone Cement1件: Cobalt---1件: 46 💬
1109Cobamamide1件: Cobamamide1件: Cobamamide 💬 --1件: 299 💬
1110Cobiprostone1件: Cobiprostone1件: Cobiprostone 💬 --1件: 46 💬
1111COBITOLIMOD1件: Cobitolimod1件: Cobitolimod 💬 1件: TLR9 💬 10件: African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Lysosome biogenesis, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬1件: 97 💬
1112Cobitolimod 250 mg1件: Cobitolimod1件: Cobitolimod 💬 1件: TLR9 💬 10件: African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Lysosome biogenesis, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬1件: 97 💬
1113Cobitolimod 500 mg1件: Cobitolimod1件: Cobitolimod 💬 1件: TLR9 💬 10件: African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Lysosome biogenesis, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬1件: 97 💬
1114Cobitolimod 500mg1件: Cobitolimod1件: Cobitolimod 💬 1件: TLR9 💬 10件: African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Lysosome biogenesis, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬1件: 97 💬
1115Cocktail Substrates (Midazolam Oral Solution, Rosuvastatin Calcium Tablets, and Digoxin Tablets)4件: Calcium,
Digoxin,
Midazolam,
Rosuvastatin		6件: Digoxin ,
Midazolam ,
Midazolam hydrochloride ,
Rosuvastatin calcium ,
Midazolam maleate ,
Rosuvastatin 💬 		21件: ATP1A1,
ATP1A2,
ATP1A3,
ATP1A4,
GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ,
HMGCR 💬 		30件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Cadherin signaling, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cytoskeleton in muscle cells, Endocrine and other factor-regulated calcium reabsorption, GABAergic synapse, Gastric acid secretion, Insulin secretion, Mineral absorption, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Taste transduction, Terpenoid backbone biosynthesis, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 67 💬
1116Cocoa1件: Cocoa---1件: 6 💬
1117Coconut1件: Coconut---2件: 13, 53 💬
1118Coconut oil2件: Coconut,
Coconut oil		1件: Coconut oil 💬 --1件: 13 💬
1119Coconut oil and epigallocatechin gallate4件: Coconut,
Coconut oil,
Epigallocatechin,
Epigallocatechin gallate		1件: Coconut oil 💬 --1件: 13 💬
1120Cod liver oil1件: Cod liver oil1件: Cod liver oil 💬 --1件: 46 💬
1121Code ATC:L01XC04----1件: 65 💬
1122Coenzym Q10 Nanodispersion----2件: 5, 6 💬
1123Coenzym Q10, Ubiquinon, Ubichinon----2件: 5, 6 💬
1124Coenzyme A1件: Coenzyme A---1件: 246 💬
1125Coenzyme Q----1件: 13 💬
1126Coenzyme Q-10 in Normal Control subjects----1件: 86 💬
1127Coenzyme Q-10 in Pulmonary Hypertension subjects----1件: 86 💬
1128Coenzyme Q10----11件: 2, 5, 6, 8, 10, 18, 49, 57, 107, 113, 193 💬
1129Coenzyme Q10 and Lisinopril1件: Lisinopril2件: Lisinopril ,
Lisinopril 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 113 💬
1130Coenzyme Q10 Nanodispersion (Nanoquinone)----1件: 6 💬
1131Coenzyme Q10 with vitamin E1件: Vitamin E1件: Vitamin E 💬 --1件: 6 💬
1132CoenzymeQ10----1件: 21 💬
1133Cofactor supplementation (thiamine, riboflavin, L-carnitine)2件: Riboflavin,
Thiamine		4件: Riboflavin ,
Thiamine hydrochloride ,
Thiamine mononitrate ,
Thiamine 💬 		--1件: 265 💬
1134COFFEE COAL----1件: 97 💬
1135Cogane™ (PYM50028)----1件: 6 💬
1136Cognixion + Apple Vision Pro1件: Apple---1件: 2 💬
1137Cohort 1 0.225g----1件: 240 💬
1138Cohort 1: 1.0 x 10^8 PolyTregs----1件: 35 💬
1139Cohort 1: hATG, CsA, EPAG Day 14 to Month 6----1件: 60 💬
1140Cohort 1: JMKX003142 and itraconazole1件: Itraconazole1件: Itraconazole 💬 --1件: 67 💬
1141Cohort 1:Nilotinib Oral Capsules (150mg or 300mg)1件: Nilotinib1件: Nilotinib 💬 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬 		35件: Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 6 💬
1142Cohort 2 0.75g----1件: 240 💬
1143Cohort 2: 2.5x10^8 PolyTregs----1件: 35 💬
1144Cohort 2: hATG, CsA, EPAG Day 14 to Month 3----1件: 60 💬
1145Cohort 2: JMKX003142 and rifampicin----1件: 67 💬
1146Cohort 2: Nilotinib Oral Capsules (dose to be determined from Cohort 1)1件: Nilotinib1件: Nilotinib 💬 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬 		35件: Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 6 💬
1147Cohort 3 2.25 g----1件: 240 💬
1148Cohort 3: hATG, CsA (dose reduced), EPAG day 1 to month 6----1件: 60 💬
1149COL7A1-SIN retroviral vector engineered autologous tissue-engineered skin----1件: 36 💬
1150COLAL PRED----1件: 97 💬
1151COLAL-PRED----1件: 97 💬
1152COLAL-PRED®----1件: 97 💬
1153COLCHICINA----1件: 2 💬
1154COLCHICINA LIRCA - 1 MG COMPRESSE 60 COMPRESSE----1件: 2 💬
1155Colchicine1件: Colchicine1件: Colchicine 💬 9件: TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		12件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬9件: 2, 42, 46, 50, 56, 93, 97, 210, 266 💬
1156Colchicine 1 MG Oral Tablet1件: Colchicine1件: Colchicine 💬 9件: TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		12件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬1件: 2 💬
1157Colchicine sprinkle capsules1件: Colchicine1件: Colchicine 💬 9件: TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		12件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬1件: 266 💬
1158Cold Cadioplegia----1件: 215 💬
1159COLECALCIFEROL1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬4件: 13, 46, 96, 228 💬
1160COLECALCIFEROL CONCENTRATE (OILY FORM)----1件: 13 💬
1161Colecalciferol D3 (Vigantol Oil)----2件: 96, 97 💬
1162Colectomy----1件: 97 💬
1163Colesevelam1件: Colesevelam2件: Colesevelam hydrochloride ,
Colesevelam 💬 		--3件: 79, 96, 260 💬
1164Colesevelam HCl1件: Colesevelam2件: Colesevelam hydrochloride ,
Colesevelam 💬 		--1件: 79 💬
1165Colesevelam hydrochloride1件: Colesevelam2件: Colesevelam hydrochloride ,
Colesevelam 💬 		--1件: 79 💬
1166Colesevelam hydrochloride film-coated tablets1件: Colesevelam2件: Colesevelam hydrochloride ,
Colesevelam 💬 		--1件: 79 💬
1167Colestipol1件: Colestipol2件: Colestipol hydrochloride ,
Colestipol 💬 		--1件: 254 💬
1168COLESTIRAMINA----1件: 13 💬
1169COLESTYRAMINE----1件: 254 💬
1170Colfinair 2 MIU Powder for Nebuliser Solution----1件: 299 💬
1171COLIMICINA - 1000000 U/4 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO INTRAMUSCOLARE1 FLACONCINO POLVERE + 1 FIALA SOLVENTE 4 ML----1件: 299 💬
1172COLIMYCINE inhalation----1件: 299 💬
1173COLIMYCINE injectable----1件: 299 💬
1174COLISTIMETATO SODICO----1件: 299 💬
1175Colistimethat-Natrium----1件: 299 💬
1176COLISTIMETHATE1件: Colistimethate1件: Colistimethate sodium 💬 --1件: 299 💬
1177Colistimethate 75 mg inhaled two times daily1件: Colistimethate1件: Colistimethate sodium 💬 --1件: 299 💬
1178COLISTIMETHATE SODIUM1件: Colistimethate1件: Colistimethate sodium 💬 --1件: 299 💬
1179COLISTIMETHATE SODIUM (A COMPONENT)1件: Colistimethate1件: Colistimethate sodium 💬 --1件: 299 💬
1180Colistimethate sodium (BAN, USAN), Colistimethatum natricum, Colistin sodium methanesulfonate2件: Colistimethate,
Colistin		3件: Colistimethate sodium ,
Colistin sulfate ,
Colistin 💬 		--1件: 299 💬
1181Colistimethate sodium (CMS)1件: Colistimethate1件: Colistimethate sodium 💬 --1件: 299 💬
1182Colistimethate sodium (promixin)1件: Colistimethate1件: Colistimethate sodium 💬 --1件: 299 💬
1183COLISTIN1件: Colistin2件: Colistin sulfate ,
Colistin 💬 		--1件: 299 💬
1184Colistin CF1件: Colistin2件: Colistin sulfate ,
Colistin 💬 		--1件: 299 💬
1185Colistin Forest - Trockenstechampullen mit Lösungsmittel1件: Colistin2件: Colistin sulfate ,
Colistin 💬 		--1件: 299 💬
1186COLISTIN MESILATE SODIUM1件: Colistin2件: Colistin sulfate ,
Colistin 💬 		--1件: 299 💬
1187Colistineb----1件: 299 💬
1188COLISTINEB 2MUI----1件: 299 💬
1189Collagen-based adhesion barrier----1件: 70 💬
1190Collagenase----1件: 162 💬
1191Collect of 10 ml of peripheric blood for DNA extraction----1件: 46 💬
1192Collection of Arterial pressure, metabolic data, kidney function, proteinuria and hematuria before and after KATRIO initiation----1件: 299 💬
1193Collection of biological sample (blood and/or CSF)----2件: 2, 6 💬
1194Collection of biological samples----1件: 63 💬
1195Collection of blood and urine----1件: 25 💬
1196Collection of blood, feces and urine. For UC: collection of 8 additional biopsies----1件: 97 💬
1197Collection of samples----4件: 49, 65, 95, 107 💬
1198Collection of samples of blood and urine----1件: 167 💬
1199Colobreathe----1件: 299 💬
1200Colomycin----1件: 299 💬
1201Colon Endoscopy Procedure----1件: 97 💬
1202Colon KCC Heptapeptide----1件: 97 💬
1203Colon preparation for colonoscopy----1件: 97 💬
1204Colonoscopic fecal microbiota material (colo-FMT)1件: Fecal microbiota---1件: 96 💬
1205Colonoscopy----2件: 96, 97 💬
1206Colonoscopy after bowel cleansing----1件: 97 💬
1207Colonoscopy with Indigo-Carmine chromoendoscopy1件: Indigo---1件: 97 💬
1208Colony-purified Bacteroides thetaiotaomicron (B.theta)1件: Bacteroides thetaiotaomicron---1件: 96 💬
1209Colorectal biopsies----1件: 97 💬
1210ColoVit capsule----1件: 96 💬
1211Coltect----1件: 97 💬
1212Combination----1件: 46 💬
1213Combination antiviral therapy----1件: 93 💬
1214Combination fish oil and borage seed oil1件: Fish oil---1件: 46 💬
1215Combination injection of EPO and G-CSF----1件: 6 💬
1216Combination of a single dose anti-CD20 antibody and bortezomib1件: Bortezomib1件: Bortezomib 💬 1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 61 💬
1217Combination of DMARDs----1件: 107 💬
1218Combination of fish oil and colesevelam2件: Colesevelam,
Fish oil		2件: Colesevelam hydrochloride ,
Colesevelam 💬 		--1件: 260 💬
1219Combination of Minocycline and MTX or MTX alone1件: Minocycline2件: Minocycline hydrochloride ,
Minocycline 💬 		--1件: 46 💬
1220Combination of Navepegritide and Lonapegsomatropin administered as two separate s.c. injections2件: Lonapegsomatropin,
Navepegritide		2件: Lonapegsomatropin ,
Navepegritide 💬 		2件: GHR,
NPR2 💬 		10件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Purine metabolism, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 276 💬
1221Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine3件: Azathioprine,
Dexamethasone,
Rituximab		6件: Azathioprine ,
Dexamethasone ,
Dexamethasone sodium phosphate ,
Rituximab ,
Azathioprine sodium ,
Dexamethasone phosphate 💬 		2件: MS4A1,
NR3C1 💬 		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 35 💬
1222Combination of Rituximab1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 63 💬
1223Combination of Rituximab with subcutaneous belimumab2件: Belimumab,
Rituximab		2件: Rituximab ,
Belimumab 💬 		2件: MS4A1,
TNFSF13B 💬 		5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 63 💬
1224Combination of thrombopoietin mimetic and cyclosporin A1件: Thrombopoietin---1件: 60 💬
1225Combination Oral Budesonide and Rectal Hydrocortisone2件: Budesonide,
Hydrocortisone		2件: Hydrocortisone ,
Budesonide 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1226Combination Product:----1件: 86 💬
1227Combination Product: 1.5g enriched pomegranate muffins1件: Pomegranate---1件: 97 💬
1228Combination Product: 3g enriched pomegranate muffins1件: Pomegranate---1件: 97 💬
1229Combination Product: 68Ga-DOTATATE PET/CT1件: Dotatate---1件: 238 💬
1230Combination Product: Active treatment with dual therapy----1件: 2 💬
1231Combination Product: Anifrolumab (blinded)1件: Anifrolumab1件: Anifrolumab 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬2件: 50, 51 💬
1232Combination Product: Anifrolumab (unblinded, open label)1件: Anifrolumab1件: Anifrolumab 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬2件: 50, 51 💬
1233Combination Product: Anifrolumab + APFS1件: Anifrolumab1件: Anifrolumab 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 49 💬
1234Combination Product: Beclomethasone dipropionate in addition to MC-EVOO1件: Beclomethasone dipropionate3件: Beclomethasone dipropionate ,
Beclometasone ,
Beclomethasone dipropionate monohydrate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1235Combination Product: Beclomethasone dipropionate in addition to refined oil1件: Beclomethasone dipropionate3件: Beclomethasone dipropionate ,
Beclometasone ,
Beclomethasone dipropionate monohydrate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1236Combination Product: Belimumab1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
1237Combination Product: BMN 111 administration via Injector Pen----1件: 276 💬
1238Combination Product: CDED (Crohn's Disease Exclusion Diet) in addition to anti-TNF therapy----2件: 96, 97 💬
1239Combination Product: Claseprubart1件: Claseprubart---1件: 11 💬
1240Combination Product: Combination of Dolutegravir + Tenofovir DF for treatment of HTLV-1 infection2件: Dolutegravir,
Tenofovir		3件: Tenofovir ,
Dolutegravir ,
Dolutegravir sodium 💬 		--1件: 26 💬
1241Combination Product: Combination Therapy----1件: 79 💬
1242Combination Product: Diosmin1件: Diosmin1件: Diosmin 💬 --1件: 51 💬
1243Combination Product: Efgartigimod + Thymectomy----1件: 11 💬
1244Combination Product: Efgartigimod PH20 SC----2件: 11, 51 💬
1245Combination Product: EGCG 300 mg + Nintedanib1件: Nintedanib2件: Nintedanib esylate ,
Nintedanib 💬 		8件: FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
KDR,
PDGFRA,
PDGFRB 💬 		36件: Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬1件: 85 💬
1246Combination Product: EGCG 300 mg + Pirfenidone1件: Pirfenidone1件: Pirfenidone 💬 6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬 		83件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85 💬
1247Combination Product: EGCG 600 mg + Nintedanib1件: Nintedanib2件: Nintedanib esylate ,
Nintedanib 💬 		8件: FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
KDR,
PDGFRA,
PDGFRB 💬 		36件: Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬1件: 85 💬
1248Combination Product: EGCG 600 mg + Pirfenidone1件: Pirfenidone1件: Pirfenidone 💬 6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬 		83件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85 💬
1249Combination Product: eneboparatide1件: Eneboparatide1件: Eneboparatide 💬 1件: PTH1R 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
1250Combination Product: Exercise, and methotrexate1件: Methotrexate2件: Methotrexate ,
Methotrexate sodium 💬 		2件: DHFR,
DHFR2 💬 		3件: Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬1件: 46 💬
1251Combination Product: Fecal Microbiota Transplant1件: Fecal microbiota---1件: 6 💬
1252Combination Product: Fluorescence molecular imaging procedure using vedolizumab-800CW with prior administration of unlabeled vedolizumab1件: Vedolizumab1件: Vedolizumab 💬 2件: ITGA4,
ITGB7 💬 		18件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬2件: 96, 97 💬
1253Combination Product: Gefurulimab1件: Gefurulimab1件: Gefurulimab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 11 💬
1254Combination Product: Gene therapy: GS030-DP AND Medical device: GS030-MD1件: GS030-DP---1件: 90 💬
1255Combination Product: Goldic serum----1件: 70 💬
1256Combination Product: Human induced pluripotent stem cell-derived dopaminergic progenitors (CT1-DAP001)----1件: 6 💬
1257Combination Product: Humira (adalimumab)1件: Adalimumab1件: Adalimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
1258Combination Product: Implantable System for Remodulin (treprostinil)1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
1259Combination Product: INBRIJA®----1件: 6 💬
1260Combination Product: Intravenous immunglobulin + Thymectomy----1件: 11 💬
1261Combination Product: L-dopa 140 mg----1件: 6 💬
1262Combination Product: L-dopa 35 mg----1件: 6 💬
1263Combination Product: L-dopa 70mg----1件: 6 💬
1264Combination Product: L-dopa 70mg/carbidopa 7mg1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
1265Combination Product: Laser, exercise, and methotrexate1件: Methotrexate2件: Methotrexate ,
Methotrexate sodium 💬 		2件: DHFR,
DHFR2 💬 		3件: Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬1件: 46 💬
1266Combination Product: Levodopa Cyclops®1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1267Combination Product: lipid injectable emulsion with Fish oil1件: Fish oil---1件: 294 💬
1268Combination Product: mavrilimumab1件: Mavrilimumab1件: Mavrilimumab 💬 1件: CSF2RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 41 💬
1269Combination Product: Methotrexate1件: Methotrexate2件: Methotrexate ,
Methotrexate sodium 💬 		2件: DHFR,
DHFR2 💬 		3件: Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬1件: 46 💬
1270Combination Product: mirdametinib with radiation1件: Mirdametinib1件: Mirdametinib 💬 2件: MAP2K1,
MAP2K2 💬 		90件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cadherin signaling, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Efferocytosis, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34 💬
1271Combination Product: ND0612 Solution for SC infusion----1件: 6 💬
1272Combination Product: ofatumumab with AI1件: Ofatumumab1件: Ofatumumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
1273Combination Product: ofatumumab with PRF1件: Ofatumumab1件: Ofatumumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
1274Combination Product: Osteoplastic material based on octacalcium phosphate and biologically active nucleic acids for bone tissue regeneration Nucleostim-VEGF (Histograft)----1件: 70 💬
1275Combination Product: Palopegteriparatide Control Arm1件: Palopegteriparatide1件: Palopegteriparatide 💬 1件: PTH1R 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
1276Combination Product: Palopegteriparatide Experimental Arm1件: Palopegteriparatide1件: Palopegteriparatide 💬 1件: PTH1R 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
1277Combination Product: Pozelimab/Cemdisiran2件: Cemdisiran,
Pozelimab		1件: Pozelimab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 15 💬
1278Combination Product: PRP combined Magnovision----1件: 90 💬
1279Combination Product: Ravulizumab OBDS1件: Ravulizumab1件: Ravulizumab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62 💬
1280Combination Product: Ripertamab/Eltrombopag2件: Eltrombopag,
Ripertamab		2件: Eltrombopag olamine ,
Eltrombopag choline 💬 		1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬1件: 63 💬
1281Combination Product: SP-101 and doxorubicin Cohort 12件: Doxorubicin,
SP-101		2件: Doxorubicin hydrochloride ,
Doxorubicin 💬 		--1件: 299 💬
1282Combination Product: SP-101 and doxorubicin Cohort 22件: Doxorubicin,
SP-101		2件: Doxorubicin hydrochloride ,
Doxorubicin 💬 		--1件: 299 💬
1283Combination Product: Standard of Care----1件: 62 💬
1284Combination Product: The addition of sodium hyaluronate to poly (cinnamyl alcohol-RRB- produces a more stable foam2件: Cinnamyl alcohol,
Hyaluronic acid		2件: Hyaluronate sodium ,
Hyaluronic acid 💬 		--1件: 279 💬
1285Combination Product: TransCon PTH----1件: 235 💬
1286Combination Product: Treprostinil via implanted pump1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
1287Combination Product: Twice daily 90 mg hydrocortisone acetate suppository administered with Sephure applicator3件: Acetate,
Hydrocortisone,
Hydrocortisone acetate		2件: Hydrocortisone ,
Hydrocortisone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1288Combination Product: Yu-Tone Music Intervention----1件: 49 💬
1289Combination Steroid----1件: 46 💬
1290Combination therapy with vigabatrin and prednisolone2件: Prednisolone,
Vigabatrin		2件: Prednisolone ,
Vigabatrin 💬 		2件: ABAT,
NR3C1 💬 		7件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬1件: 145 💬
1291Combination with dopamine agonist cabergoline2件: Cabergoline,
Dopamine		3件: Dopamine hydrochloride ,
Cabergoline ,
Dopamine 💬 		6件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5,
PRL 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 77 💬
1292Combination with somatostatin analogue octreotide2件: Octreotide,
Somatostatin		6件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Somatostatin ,
Octreotide hydrochloride 💬 		5件: SSTR1,
SSTR2,
SSTR3,
SSTR4,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
1293Combined antithrombotic therapy----1件: 48 💬
1294Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 85 💬
1295Combined therapy of Iguratimod and tofacitinib2件: Iguratimod,
Tofacitinib		3件: Iguratimod ,
Tofacitinib citrate ,
Tofacitinib 💬 		5件: JAK1,
JAK2,
JAK3,
NFKB1,
TYK2 💬 		85件: AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Apoptosis, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Cadherin signaling, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Chronic myeloid leukemia, Cocaine addiction, Coronavirus disease, Cytosolic DNA-sensing pathway, Diabetic cardiomyopathy, Efferocytosis, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Longevity regulating pathway, MAPK signaling pathway, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Primary immunodeficiency, Prolactin signaling pathway, Prostate cancer, RIG-I-like receptor signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway 💬1件: 46 💬
1296Combined use of TPO-RAs with low-dose anti-CD20 antibody----1件: 63 💬
1297COMBIVIR----1件: 265 💬
1298Combivir (zidovudine [AZT] / lamivudine [3TC])2件: Lamivudine,
Zidovudine		2件: Lamivudine ,
Zidovudine 💬 		--1件: 265 💬
1299Comirnaty----3件: 46, 51, 299 💬
1300Comirnaty concentrate for dispersion for injection----2件: 53, 299 💬
1301Comirnaty Konzentrat zur Herstellung einer Injektionsdispersion----1件: 13 💬
1302Commercial Formulation Etanercept1件: Etanercept1件: Etanercept 💬 2件: LTA,
TNF 💬 		66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
1303Commercial Ventavis® (iloprost)1件: Iloprost2件: Iloprost ,
Iloprost tromethamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
1304Common form supplementation----1件: 299 💬
1305Common Name: Sialic Acid----1件: 30 💬
1306Companion blood samples with procedure----4件: 13, 51, 97, 271 💬
1307Companion diagnostic (CDx)----1件: 96 💬
1308Companion Diagnostic (CDx) Testing----1件: 97 💬
1309Comparative Efficacy and Safety of Thalidomide and Sulfasalazine in Moderate to Severe Ankylosing Spondylitis: A Real-World Study from Bangladesh2件: Sulfasalazine,
Thalidomide		2件: Sulfasalazine ,
Thalidomide 💬 		1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
1310Comparator----1件: 96 💬
1311Comparator: carbidopa1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
1312Comparator: diclofenac1件: Diclofenac5件: Diclofenac potassium ,
Diclofenac sodium ,
Diclofenac ,
Diclofenac diethylamine ,
Diclofenac epolamine 💬 		2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
1313Comparator: Diclofenac sodium1件: Diclofenac5件: Diclofenac potassium ,
Diclofenac sodium ,
Diclofenac ,
Diclofenac diethylamine ,
Diclofenac epolamine 💬 		2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
1314Comparator: ezetimibe1件: Ezetimibe1件: Ezetimibe 💬 1件: NPC1L1 💬 1件: Fat digestion and absorption 💬2件: 79, 260 💬
1315Comparator: levodopa1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1316Comparator: naproxen tablet 500 mg1件: Naproxen2件: Naproxen ,
Naproxen sodium 💬 		2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
1317Comparator: niacin (+) laropiprant (MK0524A)2件: Laropiprant,
Niacin		2件: Niacin ,
Laropiprant 💬 		1件: PTGDR 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 79 💬
1318Comparators----1件: 54 💬
1319Complarate®----1件: 46 💬
1320COMPLEMENT C1 ESTERASE INHIBITOR----2件: 61, 65 💬
1321Complement protein C5 inhibitor----1件: 13 💬
1322Complete, polymeric formula, fiber, lactose and gluten free1件: Lactose2件: Anhydrous lactose ,
Lactose hydrate 💬 		--1件: 107 💬
1323Compound 1a----2件: 246, 299 💬
1324COMPOUND 21----1件: 85 💬
1325Compound thrombosis capsule sig: 1.5g/tid----1件: 90 💬
1326Compressa effervescente 0,5 mg di budesonide per uso orodispersibile1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
1327Compressa effervescente 1 mg di budesonide per uso orodispersibile1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
1328Compressed oxygen1件: Oxygen1件: Oxygen 💬 --1件: 97 💬
1329Computed Tomography----13件: 26, 28, 34, 40, 46, 49, 60, 62, 65, 96, 284, 285, 286 💬
1330COMTAN----1件: 6 💬
1331COMTAN 200* 60 CPR 200 MG----1件: 6 💬
1332COMTAN®----1件: 6 💬
1333Comtan®----1件: 6 💬
1334Comtess----1件: 6 💬
1335Comtess®----1件: 6 💬
1336Concentration unit: mg milligram(s)----1件: 254 💬
1337Concerta----1件: 203 💬
1338CONCOR MITE*28CPR 5MG----1件: 57 💬
1339Conditioned Medium (CM)----1件: 90 💬
1340Conditioning Regimen----1件: 2 💬
1341CONDUIT™ Interbody Platform composed of the EIT (Emerging Implant Technologies) Cellular Titanium®1件: Titanium---1件: 70 💬
1342CONESTAT ALFA1件: Conestat alfa1件: Conestat alfa 💬 3件: C1R,
C1S,
KLKB1 💬 		5件: Complement and coagulation cascades, Coronavirus disease, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 65 💬
1343Confirm Rx----1件: 86 💬
1344Confocal laser endomicroscopy----1件: 96 💬
1345Confortid----1件: 225 💬
1346Conivaptan1件: Conivaptan2件: Conivaptan hydrochloride ,
Conivaptan 💬 		2件: AVPR1A,
AVPR2 💬 		6件: Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬1件: 86 💬
1347Conjugated equine estrogens 0.625 mg/d + MPA 5 mg/d/10d----1件: 49 💬
1348Conjugated linoleic acid (CLA/Tonalin® FFA 80)1件: Linoleic acid---1件: 13 💬
1349Conjugated pneumococcal vaccine (Prevenar)----1件: 65 💬
1350Conjunctival impression----1件: 329 💬
1351Conscious sedation----1件: 6 💬
1352Continuation of azathioprine1件: Azathioprine2件: Azathioprine ,
Azathioprine sodium 💬 		--1件: 49 💬
1353Continuation of current HAART (boosted protease inhibitor [PI] combination + 2 NRTIs)----1件: 265 💬
1354Continue IS (B cell depletion therapy)----7件: 13, 35, 46, 49, 50, 51, 107 💬
1355Continue IS (MMF or MPA)----7件: 13, 35, 46, 49, 50, 51, 107 💬
1356Continue IS (MTX)----7件: 13, 35, 46, 49, 50, 51, 107 💬
1357CONTINUE NASAL SALINE IRRIGATION WITH OR WITHOUT STEROID----1件: 299 💬
1358Continued Ocrelizumab1件: Ocrelizumab1件: Ocrelizumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
1359Continuous Apomorphine infusion1件: Apomorphine2件: Apomorphine hydrochloride ,
Apomorphine 💬 		2件: DRD1,
DRD2 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1360Continuous Glucose Monitor----2件: 65, 298 💬
1361Continuous glucose monitor (CGM)----1件: 299 💬
1362Continuous Glucose Monitoring----3件: 70, 75, 299 💬
1363Continuous glucose monitoring (CGM)----1件: 299 💬
1364Continuous Glucose Monitoring System (CGMS)----1件: 299 💬
1365Continuous infusion Cefepime1件: Cefepime2件: Cefepime hydrochloride ,
Cefepime 💬 		--1件: 299 💬
1366Continuous infusion Ceftazidime1件: Ceftazidime2件: Ceftazidime ,
Ceftazidime 💬 		--1件: 299 💬
1367Continuous infusion Meropenem1件: Meropenem2件: Meropenem ,
Meropenem 💬 		--1件: 299 💬
1368Continuous infusion Piperacillin tazobactam2件: Piperacillin,
Tazobactam		5件: Piperacillin sodium ,
Tazobactam ,
Piperacillin ,
Tazobactam sodium ,
Piperacillin 💬 		--1件: 299 💬
1369Continuous infusion Ticarcillin-clavulanate1件: Ticarcillin2件: Ticarcillin disodium ,
Ticarcillin 💬 		--1件: 299 💬
1370Continuous intrajejunal infusion of levodopa-carbidopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1371Continuous Mononuclear Cell Collection (CMNC)----1件: 96 💬
1372Continuous oxygen1件: Oxygen1件: Oxygen 💬 --1件: 90 💬
1373Continuous Release Dopamine Agonists1件: Dopamine2件: Dopamine hydrochloride ,
Dopamine 💬 		5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1374Continuous Subcutaneous Lisuride Infusion1件: Lisuride1件: Lisuride 💬 3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1375Contrast Enhanced Ultrasound----1件: 96 💬
1376Contrast Enhanced Voiding Urosonography with Urodynamic Testing----1件: 118 💬
1377Contrast Media, Magnetic Resonance----2件: 94, 96 💬
1378Contrast sensitivity measurement----1件: 19 💬
1379Control----8件: 2, 6, 46, 51, 90, 97, 168, 299 💬
1380Control gel----1件: 36 💬
1381Control group----6件: 2, 13, 46, 70, 235, 240 💬
1382Control Group 0.9% Isotonic Saline----1件: 299 💬
1383Control group: Clomiphene Citrate Tablets----1件: 74 💬
1384Control group: Mesalazine enema treatment1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
1385Control intervention (no dexamethasone)1件: Dexamethasone3件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
1386Control multivitamin----1件: 299 💬
1387Control surgery----1件: 6 💬
1388Controlled-ileocolonic-release nicotinamide (CICR-NAM): 1000 mg/d1件: Nicotinamide1件: Niacinamide 💬 --1件: 97 💬
1389Controlled-ileocolonic-release nicotinamide (CICR-NAM): 500 mg/d1件: Nicotinamide1件: Niacinamide 💬 --1件: 97 💬
1390Controlled-release levodopa / carbidopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1391Conventional----1件: 63 💬
1392Conventional 24-week glucocorticoid regimen----1件: 222 💬
1393Conventional DMARD combination----1件: 46 💬
1394Conventional DMARDs----1件: 46 💬
1395Conventional drug therapy(expectorant,bronchodilator)----1件: 86 💬
1396Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)7件: Acetate,
Cortisone,
Cortisone acetate,
Dexamethasone,
Hydrocortisone,
Prednisolone,
Prednisone		8件: Hydrocortisone ,
Dexamethasone ,
Prednisolone ,
Prednisone ,
Cortisone acetate ,
Dexamethasone sodium phosphate ,
Cortisone ,
Dexamethasone phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
1397Conventional ibd medical treatment----1件: 97 💬
1398Conventional medical treatment----1件: 22 💬
1399Conventional medication----1件: 6 💬
1400Conventional medicine----1件: 18 💬
1401Conventional pharmacotherapy----1件: 49 💬
1402Conventional surgery----1件: 34 💬
1403Conventional synthetic antirheumatic drugs----1件: 46 💬
1404Conventional Synthetic DMARD----1件: 46 💬
1405Conventional Therapy----5件: 14, 49, 67, 97, 222 💬
1406Conventional therapy of antiphospholipis syndrome----1件: 48 💬
1407Conventional therapy users for the last 5 years----1件: 271 💬
1408Conventional treatment----1件: 97 💬
1409Conventional treatment (glucocoticoid, immunosupressive drugs and/or mesalazine)1件: Mesalazine1件: Mesalamine 💬 --2件: 96, 97 💬
1410Conventional white-light colonoscopy----1件: 97 💬
1411Coolonic biopsies----2件: 96, 97 💬
1412Coozar----1件: 167 💬
1413COP-1/Copolymer-11件: Glatiramer1件: Glatiramer acetate 💬 20件: HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
1414Copanlisib1件: Copanlisib1件: Copanlisib 💬 2件: PIK3CA,
PIK3CD 💬 		106件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phagocytosis, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬1件: 121 💬
1415COPAXONE----1件: 13 💬
1416COPAXONE - 20 MG/ML SOLUZIONE INIETTABILE 28 SIRINGHE PRERIEMPITE----1件: 13 💬
1417COPAXONE - 20 MG/ML SOLUZIONE INIETTABILE IN SIRINGHE PRERIEMPITE 30 SIRINGHE----1件: 13 💬
1418COPAXONE - 40 MG/ML SOLUZIONE INIETTABILE IN----1件: 13 💬
1419COPAXONE - 40 MG/ML SOLUZIONE INIETTABILE IN SIRINGA PRERIEMPITA 12 SIRINGHE PRERIEMPITE DA 1 ML CON AGO----1件: 13 💬
1420Copaxone 20 mg----1件: 13 💬
1421Copaxone 20 mg/ml----1件: 13 💬
1422COPAXONE 20 mg/ml solución inyectable en jeringa precargada----1件: 13 💬
1423Copaxone 20 mg/ml solución para inyección en jeringa precargada----1件: 13 💬
1424Copaxone 20 mg/ml Solution for Injection, pre-filled syringe----1件: 13 💬
1425Copaxone 20 mg/ml, Solution for Injection, pre-filled syringes----1件: 13 💬
1426Copaxone 20mg/ml Solution for Injection, pre-filled syringe----1件: 13 💬
1427Copaxone 40 mg/ml----1件: 13 💬
1428Copaxone 40 mg/ml solution for injection, pre-filled syringe----1件: 13 💬
1429COPAXONE*SC 28SIR 20MG/ML----1件: 13 💬
1430Copaxone-Teva----1件: 13 💬
1431Copaxone®----1件: 13 💬
1432Copegus----1件: 2 💬
1433Copolymer 1----1件: 13 💬
1434Copper1件: Copper---4件: 2, 169, 170, 171 💬
1435COPPER (64CU) CHLORIDE1件: Copper---1件: 171 💬
1436Copper histidinate1件: Copper---1件: 169 💬
1437Copper Histidine2件: Copper,
Histidine		1件: Histidine 💬 --2件: 169, 170 💬
1438CoQ10----4件: 5, 6, 8, 96 💬
1439COQUN----1件: 90 💬
1440COR-003----1件: 75 💬
1441COR-1----1件: 57 💬
1442Coramitug1件: Coramitug1件: Coramitug 💬 1件: TTR 💬 1件: Thyroid hormone synthesis 💬1件: 28 💬
1443Cord blood----1件: 60 💬
1444Cord Blood Infusion----1件: 60 💬
1445Cord blood sampling----1件: 227 💬
1446Cord Blood Stem Cell Transplantation----1件: 97 💬
1447Cord Blood Transplant----1件: 60 💬
1448Cord Blood Transplantation----1件: 60 💬
1449Cord Blood Units----1件: 60 💬
1450Cord sampling----1件: 227 💬
1451Core decompression----1件: 71 💬
1452Core decompression/BMC implantation----1件: 71 💬
1453Core decompression/PREOB® implantation----1件: 71 💬
1454Corlanor----1件: 57 💬
1455CORMETO----1件: 75 💬
1456CORMETO - 250 MG CAPSULE MOLLI 50 CAPSULE IN FLACONE HDPE----1件: 75 💬
1457Corn1件: Corn---2件: 46, 240 💬
1458Corn oil capsules1件: Corn---1件: 46 💬
1459Corn starch tablets----1件: 179 💬
1460Corn/soy oil1件: Corn---1件: 240 💬
1461Cornstarch----1件: 257 💬
1462Cornstarch control----1件: 90 💬
1463CORT113176----1件: 2 💬
1464CORT1251341件: Relacorilant1件: Relacorilant 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 75 💬
1465CORT125134Pharmaceutical Form: Capsule, soft----1件: 75 💬
1466CORTANCYL----1件: 41 💬
1467CORTANCYL 20 mg----2件: 35, 162 💬
1468Cortancyl ® 1 mg----1件: 41 💬
1469Cortancyl ® 20 mg----1件: 41 💬
1470Cortancyl ® 5 mg----1件: 41 💬
1471Cortecosteroid----1件: 96 💬
1472Cortef----2件: 81, 83 💬
1473Cortef (hydrocortisone)1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 83 💬
1474Cortef 10mg----1件: 81 💬
1475Cortef 5 mg----1件: 83 💬
1476Cortef 5mg----1件: 81 💬
1477Corticoids+ tocilizumab 8mg/Kg/4 weeks1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 41 💬
1478Corticosteriod for treated patients----1件: 63 💬
1479Corticosteroid----12件: 13, 42, 43, 44, 45, 66, 84, 96, 97, 113, 222, 223 💬
1480Corticosteroid (CS)----1件: 41 💬
1481Corticosteroid and azathioprine1件: Azathioprine2件: Azathioprine ,
Azathioprine sodium 💬 		--4件: 42, 43, 44, 45 💬
1482Corticosteroid and non-biological agents.----1件: 46 💬
1483Corticosteroid injection----1件: 46 💬
1484Corticosteroid or NSAID----1件: 46 💬
1485Corticosteroid treatment (Methylprednisolone or prednisolone)2件: Methylprednisolone,
Prednisolone		3件: Methylprednisolone ,
Prednisolone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 64 💬
1486Corticosteroide----1件: 113 💬
1487Corticosteroids----13件: 41, 46, 49, 63, 64, 97, 107, 113, 164, 222, 223, 296, 300 💬
1488Corticosteroids & tanCART19/20----1件: 13 💬
1489Corticosteroids (Aprednislon)----1件: 63 💬
1490Corticosteroids (prednisone or prednisolone)2件: Prednisolone,
Prednisone		2件: Prednisolone ,
Prednisone 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 49, 223 💬
1491Corticosteroids + Rivaroxaban1件: Rivaroxaban1件: Rivaroxaban 💬 1件: F10 💬 1件: Complement and coagulation cascades 💬1件: 56 💬
1492Corticosteroids alone----1件: 56 💬
1493Corticosteroids and immunosuppressants----1件: 55 💬
1494Corticosteroids combined with immunoglobulin and romiplostim1件: Romiplostim1件: Romiplostim 💬 1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬1件: 63 💬
1495Corticosteroids for Systemic Use----1件: 41 💬
1496Corticosteroids only----1件: 97 💬
1497Corticosteroids'therapy----1件: 35 💬
1498Corticotherapy----1件: 66 💬
1499Corticotrophin 80 units----1件: 46 💬
1500Corticotropin1件: Corticotropin2件: Corticotropin ,
Corticotropin, repository 💬 		1件: MC2R 💬 6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬10件: 2, 13, 46, 75, 78, 81, 84, 145, 205, 222 💬
1501Corticotropin-Releasing Hormone1件: Corticotropin2件: Corticotropin ,
Corticotropin, repository 💬 		1件: MC2R 💬 6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 205 💬
1502CortimentMMX 9 mg----1件: 97 💬
1503Cortisol1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
1504Cortison----1件: 81 💬
1505Cortisone1件: Cortisone1件: Cortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
1506Cortisone acetate3件: Acetate,
Cortisone,
Cortisone acetate		2件: Cortisone acetate ,
Cortisone 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
1507Corynebacterium diphtheriae1件: Corynebacterium diphtheriae---1件: 11 💬
1508Cosentyx----4件: 41, 107, 269, 271 💬
1509COSENTYX - 150 MG - SOLUZIONE INIETTABILE IN SIRINGA PRERIEMPITA -USO SOTTOCUTANEO - SIRINGA (VETRO) 1 ML (150MG/ML)- 1 SIRINGA PRERIEMPITA----1件: 107 💬
1510COSENTYX - 150 MG - SOLUZIONE INIETTABILE IN SIRINGA PRERIEMPITA -USO SOTTOCUTANEO - SIRINGA (VETRO) 1 ML (150MG/ML)- 2 SIRINGHE PRERIEMPITE----1件: 107 💬
1511Cosentyx 300 mg solution for injection in pre-filled syringe----1件: 41 💬
1512Cosentyx 300mg solution for injection in pre-filled syringe----1件: 41 💬
1513Cosentyx®----1件: 269 💬
1514Cosintropina acetato----1件: 113 💬
1515CosmoFer----2件: 96, 97 💬
1516CosmoFer 50mg/ml solution for infusion or injection----2件: 96, 97 💬
1517Costicosteroids----1件: 26 💬
1518Cosyntropin----1件: 113 💬
1519Cosyntropin acetate2件: Acetate,
Tetracosactide		2件: Cosyntropin ,
Tetracosactide acetate 💬 		1件: MC2R 💬 6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 113 💬
1520Cosyntropin Injectable Suspension 1 MG/ML + vigabatrin1件: Vigabatrin1件: Vigabatrin 💬 1件: ABAT 💬 6件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬1件: 145 💬
1521Cosyntropin Injectable Suspension, 1 mg/mL----1件: 145 💬
1522Cotoretigene Toliparvovec1件: Cotoretigene toliparvovec---1件: 90 💬
1523Cotrimoxazole----2件: 85, 97 💬
1524Cotton1件: Cotton---2件: 35, 162 💬
1525Cotton gauze with petrolatum2件: Cotton,
Petrolatum		2件: Petrolatum, white ,
Petrolatum 💬 		--2件: 35, 162 💬
1526COUMADIN----1件: 48 💬
1527COVERSIN----2件: 62, 109 💬
1528Coversyl----2件: 19, 167 💬
1529Coversyl (perindopril)1件: Perindopril3件: Perindopril erbumine ,
Perindopril ,
Perindopril arginine 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 167 💬
1530Coversyl 5mg----1件: 57 💬
1531Coversyl PLUS----1件: 19 💬
1532COVID-19 mRNA Vaccine (nucleoside modified)----3件: 13, 46, 51 💬
1533COVID-19 mRNA vaccine (nucleoside-modified)----4件: 13, 46, 51, 299 💬
1534COVID-19 mRNA vaccine Moderna (CX-024414)----4件: 13, 46, 51, 299 💬
1535COVID-19 vaccination----1件: 13 💬
1536COVID-19 vaccine----4件: 46, 49, 51, 97 💬
1537COVID-19 vaccine (Ad26.COV2-S [recombinant])----1件: 299 💬
1538COVID-19 Vaccine (ChAdOx1-S [recombinant])----3件: 46, 51, 299 💬
1539COVID-19 Vaccine AstraZeneca----2件: 46, 51 💬
1540COVID-19 vaccine AstraZeneca (ChAdOx1 nCoV-19)----3件: 46, 51, 299 💬
1541COVID-19 Vaccine AstraZeneca suspension for injection COVID-19 Vaccine (ChAdOx1-S [recombinant])----1件: 53 💬
1542COVID-19 Vaccine Janssen suspension for injection----1件: 299 💬
1543COVID-19 Vaccine Janssen suspension for injection COVID-19 vaccine (Ad26.COV2-S [recombinant])----2件: 53, 299 💬
1544COVID-19 Vaccine Moderna----5件: 46, 51, 65, 272, 299 💬
1545COVID-19 Vaccine Moderna dispersion for injection----1件: 299 💬
1546COVID-19 Vaccines at a 3-month interval----2件: 46, 97 💬
1547COVID-19 Vaccines at a 6-month interval----2件: 46, 97 💬
1548COVID19 vaccine----1件: 13 💬
1549COX-2 inhibitor----1件: 165 💬
1550COYA 302----1件: 2 💬
1551Cozaar----1件: 167 💬
1552Cozaar 50----1件: 167 💬
1553COZAAR 50 mg comprimidos recubierto con pelicula----1件: 179 💬
1554COZAAR INICIO 12,5 mg comprimidos recubiertos con pelicula----1件: 167 💬
1555CP 690,550----1件: 46 💬
1556CP 690550 MR----1件: 46 💬
1557CP- 690 550----1件: 97 💬
1558CP-101----1件: 97 💬
1559CP-195,543----1件: 46 💬
1560CP-461----1件: 96 💬
1561CP-529,414/Atorvastatin1件: Atorvastatin2件: Atorvastatin calcium ,
Atorvastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬1件: 79 💬
1562CP-690, 550 - 10----1件: 46 💬
1563CP-690,500 5 mg----1件: 97 💬
1564CP-690,55-10----1件: 46 💬
1565CP-690,550----5件: 46, 96, 97, 107, 271 💬
1566CP-690,550 (tasocitinib)----1件: 46 💬
1567CP-690,550 (tofacitinib)1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬2件: 46, 107 💬
1568CP-690,550 + methotrexate1件: Methotrexate2件: Methotrexate ,
Methotrexate sodium 💬 		2件: DHFR,
DHFR2 💬 		3件: Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬1件: 46 💬
1569CP-690,550 10 mg----1件: 97 💬
1570CP-690,550 – 10----1件: 46 💬
1571CP-690,550-10----5件: 46, 96, 97, 107, 271 💬
1572CP-690-550----1件: 46 💬
1573CP-690-550-10----1件: 107 💬
1574CP-690-550-10 (DMID D1600180)----1件: 107 💬
1575CP690,550----2件: 46, 97 💬
1576CPAP group: postoperative CPAP support, non-CPAP group: oxygen 3 liters per minute (L/min) either via mask for those who were extubated or through a T-piece for those with a trash1件: Oxygen1件: Oxygen 💬 --1件: 330 💬
1577CPHC (carboxy pyrrolidine hexanoyl pyrrolidone carboxylate)2件: Pyrrolidine,
Pyrrolidone		---1件: 28 💬
1578CPK850----1件: 90 💬
1579CPL409116----1件: 46 💬
1580CPL500036----1件: 6 💬
1581CPL500036 - high dose----1件: 6 💬
1582CPL500036 - low dose----1件: 6 💬
1583CPSI-2364----1件: 96 💬
1584CPTX2309----2件: 46, 49 💬
1585CPV-104----1件: 223 💬
1586CPX----1件: 299 💬
1587CR 1----1件: 46 💬
1588CR 2----1件: 46 💬
1589CR 3----1件: 46 💬
1590CR0021件: CR002---1件: 299 💬
1591CR002 Liquid API1件: CR002---1件: 299 💬
1592CR0686----1件: 46 💬
1593Cr13C----1件: 113 💬
1594CR60861件: CR6086---1件: 46 💬
1595CR6086Z----1件: 46 💬
1596CR845 1.0 mg----1件: 93 💬
1597Cranberry1件: Cranberry---2件: 13, 96 💬
1598Cranberry powder1件: Cranberry---1件: 96 💬
1599CRC (A3384)----3件: 93, 297, 338 💬
1600CRC01----1件: 49 💬
1601CRC3357, ZK-355322, Leukoton----1件: 299 💬
1602CRD-TMH-001----1件: 113 💬
1603CRD007----1件: 113 💬
1604Creapure----1件: 50 💬
1605Creatine1件: Creatine---18件: 1, 2, 3, 5, 6, 8, 13, 15, 21, 46, 49, 50, 97, 113, 156, 201, 256, 337 💬
1606Creatine Monohydrate1件: Creatine---5件: 2, 8, 97, 113, 156 💬
1607Creatine-13C1件: Creatine---1件: 113 💬
1608Creatinine1件: Creatinine1件: Creatinine 💬 --9件: 2, 46, 49, 60, 66, 70, 96, 97, 222 💬
1609Crefmirlimab1件: Crefmirlimab---4件: 13, 25, 51, 53 💬
1610Crema de rapamicina al 1% y excipientes----1件: 157 💬
1611Crema placebo (excipiente)----1件: 157 💬
1612CREON----2件: 298, 299 💬
1613Creon 10.000, hårde enterokapsler----1件: 299 💬
1614Creon 10000----2件: 298, 299 💬
1615CREON 10000 Capsules----1件: 299 💬
1616Creon 25.000, hårde enterokapsler----1件: 299 💬
1617Creon 25000----2件: 298, 299 💬
1618Creon 40.000, hårde enterokapsler----1件: 299 💬
1619CREON IR----1件: 299 💬
1620Creon N----1件: 299 💬
1621CREON N 25000----1件: 299 💬
1622Creon(Pancreatin Enteric-coated Capsules)----1件: 298 💬
1623Creon36™----1件: 298 💬
1624Creon®----1件: 299 💬
1625Creon® (DR/GR)----1件: 299 💬
1626Creon® 25,000----1件: 299 💬
1627Crestor----3件: 49, 79, 299 💬
1628CRESTOR 10 mg encapsulated tablet----1件: 79 💬
1629CRESTOR 20 mg encapsulated tablet (2x10 mg)----1件: 79 💬
1630CRESTOR 5 mg encapsulated tablet----1件: 79 💬
1631Crestor Film-Coated Tablet----1件: 79 💬
1632Crestor Tablets (calcium rosuvastatin) Film-Coated tablets2件: Calcium,
Rosuvastatin		2件: Rosuvastatin calcium ,
Rosuvastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬1件: 79 💬
1633CREXONT ER----1件: 6 💬
1634CRH----1件: 310 💬
1635Crinecerfont1件: Crinecerfont1件: Crinecerfont 💬 1件: CRHR1 💬 5件: Cushing syndrome, Hormone signaling, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 81 💬
1636Crinecerfont is a novel non-peptide selective corticotropin releasing factor 1 (CRF1 ) receptor antagonist.2件: Corticotropin,
Crinecerfont		3件: Corticotropin ,
Corticotropin, repository ,
Crinecerfont 💬 		2件: CRHR1,
MC2R 💬 		7件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 81 💬
1637CrinecerfontProduct Code: NBI-74788 Pharmaceutical Form: Capsule, hardINN or Proposed INN: CrinecerfontCAS Number: 752253-39-7Current Sponsor code: NBI-74788Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 50-Pharmaceutical form of the placebo: CapsuleRoute of administration of the placebo: Oral use----1件: 81 💬
1638Crisugabalin1件: Crisugabalin---2件: 6, 13 💬
1639Crizotinib1件: Crizotinib1件: Crizotinib 💬 1件: ALK 💬 3件: Non-small cell lung cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer 💬2件: 2, 34 💬
1640CRN00808----1件: 77 💬
1641CRN00808 - is an oral non-peptide small molecule somatostatin receptor 2 (SST2)1件: Somatostatin1件: Somatostatin 💬 5件: SSTR1,
SSTR2,
SSTR3,
SSTR4,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
1642CRN00808 is an oral non-peptide small molecule somatostatin receptor 2 (SST2) agonist1件: Somatostatin1件: Somatostatin 💬 5件: SSTR1,
SSTR2,
SSTR3,
SSTR4,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
1643CRN00808 è un agonista del recettore 2 della somatostatina (SST2), orale, non peptidico a piccole dimensioni molecolari1件: Somatostatin1件: Somatostatin 💬 5件: SSTR1,
SSTR2,
SSTR3,
SSTR4,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
1644CRN00808.HCl----1件: 77 💬
1645Crocin1件: Crocin---1件: 6 💬
1646Crocin and Apigenin2件: Apigenin,
Crocin		---1件: 6 💬
1647Crohn's Disease----1件: 96 💬
1648Crohn's disease exclusion diet----1件: 96 💬
1649Crohn's disease exclusion diet (CDED)----1件: 96 💬
1650Crohns Disease Exclusion Diet + PEN----1件: 96 💬
1651Cromoglicato disodico----1件: 85 💬
1652Cromolyn sodio (cromoglicato disodico, DSCG)----1件: 85 💬
1653Cromolyn Sodium----1件: 85 💬
1654Cromolyn Sodium (17.1 mg BID)----1件: 2 💬
1655Cromolyn Sodium (34.2 mg BID)----1件: 2 💬
1656Cromolyn sodium [Disodium Cromoglycate]----1件: 85 💬
1657Crono Five ambulatory pump----1件: 86 💬
1658Crovalimab1件: Crovalimab1件: Crovalimab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬3件: 48, 62, 109 💬
1659CrovalimabProduct Code: RO7112689/F03-10Pharmaceutical Form: Solution for injection/infusionINN or Proposed INN: CROVALIMABCurrent Sponsor code: RO7112689Other descriptive name: C5 inh MAb, SKY59, RO/CH7092230Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 170-Product Name: CrovalimabProduct Code: RO7112689/F03-01Pharmaceutical Form: Solution for injection/infusionINN or Proposed INN: CROVALIMABCurrent Sponsor code: RO7112689Other descriptive name: C5 inh MAb, SKY59, RO/CH7092230Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 170-----1件: 109 💬
1660CROWN----1件: 96 💬
1661CRx-102----1件: 46 💬
1662CRx-102 (2.7/180)----1件: 46 💬
1663CRx-102 (2.7/360)----1件: 46 💬
1664CRX-1391件: CRx-139---1件: 46 💬
1665CRx-150----1件: 46 💬
1666CRYOPRESERVED AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH A LENTIVIRAL VECTOR CONTAINING HUMAN SGSH GENE----1件: 19 💬
1667Cryopreserved Autologous CD34+ cells transduced with pCCLCHIM-p47----1件: 65 💬
1668Cryopreserved EFS-ADA LV transduced patient CD34+ cells----1件: 65 💬
1669Cryopreserved G2SCID lentiviral vector transduced patient CD34+ cells----1件: 65 💬
1670Cryopreserved myelin-derived peptide-loaded tolerogenic dendritic cells----1件: 13 💬
1671Cryostor CS10----1件: 53 💬
1672Cryosupernatant plasma----1件: 64 💬
1673Crystalline Calcium Carbonate2件: Calcium,
Calcium carbonate		2件: Calcium carbonate ,
Calcium carbonate 💬 		--1件: 235 💬
1674Crystalline calcium supplements1件: Calcium---1件: 235 💬
1675Crystalline cholesterol oil-based suspension1件: Cholesterol1件: Cholesterol 💬 --1件: 310 💬
1676Crysvita (burosumab-twza) Treatment1件: Burosumab1件: Burosumab 💬 1件: FGF23 💬 11件: Breast cancer, Calcium signaling pathway, Gastric cancer, MAPK signaling pathway, Melanoma, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton 💬1件: 238 💬
1677CS (corticosteroids) Only----1件: 97 💬
1678CS-0777 tablets----1件: 13 💬
1679CS0159----2件: 93, 94 💬
1680CS1----1件: 86 💬
1681CS1 Administration----1件: 86 💬
1682CS10BR05----1件: 17 💬
1683CS20AT04 (allogenic bone marrow derived mesenchymal stem cell)----1件: 49 💬
1684Csa----2件: 49, 60 💬
1685CsA+ATG+Herombopag----1件: 60 💬
1686CsA+Herombopag----1件: 60 💬
1687CSCC_ASC(22)----1件: 53 💬
1688CsDMARD(s)----1件: 46 💬
1689CsDMARDs----1件: 46 💬
1690CSF collection by lumbar puncture (Optional)----1件: 13 💬
1691CSF sampling----1件: 13 💬
1692CSL312----2件: 65, 85 💬
1693CSL312 garadacimab1件: Garadacimab1件: Garadacimab 💬 1件: F12 💬 1件: Complement and coagulation cascades 💬2件: 65, 85 💬
1694CSL787----1件: 299 💬
1695CSL830----1件: 65 💬
1696CSM allogéniques issues de cordons ombilicaux ( MTI-PP)----1件: 49 💬
1697CSs----1件: 107 💬
1698CST-103----1件: 6 💬
1699CST-107----1件: 6 💬
1700CST-139----1件: 6 💬
1701CSTI-500----1件: 193 💬
1702CT Scan----1件: 65 💬
1703CT- P10----1件: 46 💬
1704CT-G20----1件: 58 💬
1705CT-P10----1件: 46 💬
1706CT-P13----4件: 46, 96, 97, 271 💬
1707CT-P13 SC (Infliximab)1件: Infliximab1件: Infliximab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
1708CT-P13 SC Auto-Injector----1件: 46 💬
1709CT-P17----1件: 46 💬
1710CT-P17 SC----1件: 46 💬
1711CT-P17 SC AI (adalimumab)1件: Adalimumab1件: Adalimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
1712CT-P47----1件: 46 💬
1713CT-P47 AI (tocilizumab)1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
1714CT-P47 PFS (tocilizumab)1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
1715CT-P53----1件: 13 💬
1716CT103A1件: CT103A---4件: 11, 13, 14, 16 💬
1717CT103A cells1件: CT103A---4件: 11, 13, 14, 16 💬
1718CTH120----1件: 206 💬
1719CTI-1601----1件: 18 💬
1720CTLA4-IgG4m (RG2077)----1件: 49 💬
1721CTLA4Ig----5件: 46, 49, 96, 223, 271 💬
1722CTX----1件: 223 💬
1723CTX combined with Glucocorticoids----1件: 222 💬
1724CTX-4430----1件: 299 💬
1725CTX112----3件: 51, 61, 63 💬
1726CTX310----1件: 79 💬
1727Cu(II)ATSM----2件: 2, 6 💬
1728Cu-64 DOTATATE1件: Dotatate---1件: 84 💬
1729CU104----1件: 97 💬
1730Cudetaxestat1件: Cudetaxestat---1件: 85 💬
1731Cudetaxestat (BLD-0409)1件: Cudetaxestat---1件: 85 💬
1732Cufence----2件: 58, 171 💬
1733Cufence (trientine dihydrochloride)1件: Triethylenetetramine2件: Trientine hydrochloride ,
Trientine tetrahydrochloride 💬 		--1件: 171 💬
1734CUG252----1件: 49 💬
1735Cultivated oral mucosal epithelial sheet transplantation----2件: 38, 162 💬
1736Culture of lymphoblastoid line from blood sample----1件: 102 💬
1737Cultured allogeneic fibroblasts----1件: 36 💬
1738Cultured mesenchymal stem cells from bone marrow isolation----1件: 71 💬
1739Cultured Thymus Tissue----1件: 65 💬
1740Cultured Thymus Tissue for Implantation (CTTI)----1件: 65 💬
1741Cultured Thymus Tissue Implantation (CTTI)----1件: 65 💬
1742Cumulative corticosteroid exposure----1件: 49 💬
1743Cupping----1件: 70 💬
1744Cuprimine (penicillamine)1件: Penicillamine1件: Penicillamine 💬 --1件: 51 💬
1745Cuprior----1件: 171 💬
1746Cuprior 150 mg----1件: 171 💬
1747Cuprior 150 mg film-coated tablets----1件: 171 💬
1748Cuprior 150mg film-coated tablets----1件: 171 💬
1749Cura-100----1件: 46 💬
1750Curcuma----1件: 96 💬
1751Curcuma Longa Extract cpl formaat 00 23,2 x 8,5 mm 723 mg----1件: 299 💬
1752CURCUMA LONGA RHIZOMA----1件: 96 💬
1753Curcumin1件: Curcumin---12件: 2, 13, 34, 36, 46, 67, 74, 94, 96, 97, 139, 299 💬
1754Curcumin (Longvida™)1件: Curcumin---1件: 46 💬
1755Curcumin Supplementation1件: Curcumin---1件: 97 💬
1756Curcumin, high phenolic extra virgin olive oil (HP-EVOO)2件: Curcumin,
Olive oil		1件: Olive oil 💬 --1件: 34 💬
1757Curcumin-based photodynamic therapy1件: Curcumin---1件: 36 💬
1758Curie Artificial Intelligence (AI) cough monitor----1件: 299 💬
1759Curosurf----1件: 211 💬
1760CurQD (Curcumin + QingDai combination)1件: Curcumin---1件: 97 💬
1761Current lipid-lowering treatment----1件: 79 💬
1762Current marketed FLOLAN (epoprostenol sodium)1件: Epoprostenol2件: Epoprostenol ,
Epoprostenol sodium 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
1763Current standard of care treatment options----1件: 49 💬
1764Current treatment of AL-CM----1件: 28 💬
1765Currently available therapy in the community----1件: 51 💬
1766Cushing's syndrome confirmation----1件: 75 💬
1767Custom Device----1件: 6 💬
1768Customized microinjection device----1件: 6 💬
1769Cutaneous biopsy----1件: 162 💬
1770Cutaneous iontophoresis of treprostinil1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 51 💬
1771CUTAQUIG----1件: 65 💬
1772CUV1647----1件: 254 💬
1773CUVITRU----1件: 65 💬
1774Cuvitru 200 mg/ml solution for subcutaneous injection----1件: 65 💬
1775CV-MG011件: CV-MG01---1件: 11 💬
1776CVD00118-E----1件: 6 💬
1777CVL-751----1件: 6 💬
1778CVN424----1件: 6 💬
1779CVN424 150 mg----1件: 6 💬
1780CVN424 75 mg----1件: 6 💬
1781CVT-301----1件: 6 💬
1782CVT-301 (Dose Level 1)----1件: 6 💬
1783CVT-301 (Dose Level 2)----1件: 6 💬
1784CVT-301 35mg----1件: 6 💬
1785CVT-301 50mg----1件: 6 💬
1786CVT-301 High Dose----1件: 6 💬
1787CVT-301 Low Dose----1件: 6 💬
1788CVT-301, LIP----1件: 6 💬
1789CVXL-0107----1件: 6 💬
1790CX-016492----1件: 245 💬
1791CX-017950----1件: 245 💬
1792CX-4945 oral formulation----1件: 331 💬
1793CX-8998----1件: 6 💬
1794Cx401----1件: 96 💬
1795CX5011件: CX501---1件: 36 💬
1796CX5161件: CX516---1件: 206 💬
1797CX516 (Ampalex®)1件: CX516---1件: 206 💬
1798Cx601----1件: 96 💬
1799CXA-101件: CXA-10---2件: 86, 222 💬
1800Cy----1件: 60 💬
1801Cy-ATG----1件: 60 💬
1802CYB704----1件: 13 💬
1803CyberKnife----1件: 6 💬
1804CYC----1件: 40 💬
1805CYC202----1件: 299 💬
1806Cyclin D1 gene (CCDN1) /immunoglobulin heavy chain (IGH) fluorescence in situ hybridization (FISH) assay----1件: 28 💬
1807Cyclo ((diaminoethyl-carbamate)HyPro-Phg-(D) Trp-Ly di-aspartate----1件: 75 💬
1808Cyclo ((diaminoethyl-carbamate)HyPro-Phg-(D) Trp-Ly pamoate----1件: 77 💬
1809Cyclo ((diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Ly di-aspartate----1件: 75 💬
1810Cyclo((diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Ly pamoate----1件: 77 💬
1811Cyclo((diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Lys pamoate----1件: 77 💬
1812Cyclo((diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Lys-Tyr(Bzl)-Phe) di-aspartate----1件: 75 💬
1813Cyclo((diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Lys-Tyr(Bzl)-Phe) pamoate----1件: 77 💬
1814Cyclo(diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Lys-Tyr(Bzl)-Phe)----2件: 75, 77 💬
1815CYCLO[L-ALANYL-L-SERYL-L-ISOLEUCYL-L-PROLYL-L-PROLYL-L-GLUTAMINYL-L-LYSYL-L-TYROSYL-D-PROLYL-L-PROLYL-(2S)-2-AMINODECANOYL-L-ALPHA-GLUTAMYL-L-THREONYL]----1件: 299 💬
1816Cyclophosfamide----1件: 13 💬
1817Cyclophosphamid1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--2件: 66, 223 💬
1818Cyclophosphamide1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--50件: 11, 13, 14, 16, 19, 20, 26, 28, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 62, 63, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 223, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
1819Cyclophosphamide (CTX)1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--2件: 28, 222 💬
1820Cyclophosphamide (CY)1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--1件: 60 💬
1821Cyclophosphamide (CY) (Plan 1)1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--3件: 60, 65, 285 💬
1822Cyclophosphamide (CY) (Plan 2)1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--3件: 60, 65, 285 💬
1823Cyclophosphamide (CYC)1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--2件: 49, 221 💬
1824Cyclophosphamide (Cytoxan)1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--1件: 65 💬
1825Cyclophosphamide (drug)1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--1件: 13 💬
1826Cyclophosphamide + pred1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--1件: 283 💬
1827Cyclophosphamide 100 mg/Kg1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--2件: 19, 222 💬
1828Cyclophosphamide 100mg1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--1件: 60 💬
1829Cyclophosphamide 1200 mg/Kg1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--2件: 19, 222 💬
1830Cyclophosphamide 150mg1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--1件: 60 💬
1831Cyclophosphamide 50mg1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--1件: 60 💬
1832Cyclophosphamide 50Mg Oral Tablet1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--1件: 162 💬
1833Cyclophosphamide added to standard immunosuppressive therapy with herombopag1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--1件: 60 💬
1834Cyclophosphamide and ATG1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--1件: 13 💬
1835Cyclophosphamide and fludarabine2件: Cyclophosphamide,
Fludarabine		4件: Cyclophosphamide ,
Fludarabine phosphate ,
Cyclophosphamide ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬4件: 11, 13, 14, 16 💬
1836Cyclophosphamide and steroids1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--2件: 222, 223 💬
1837Cyclophosphamide Dose Level 11件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--2件: 65, 284 💬
1838Cyclophosphamide Dose Level 21件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--2件: 65, 284 💬
1839Cyclophosphamide Dose Level 31件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--2件: 65, 284 💬
1840Cyclophosphamide Dose Level 41件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--2件: 65, 284 💬
1841Cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids3件: Azathioprine,
Cyclophosphamide,
Methotrexate		6件: Methotrexate ,
Azathioprine ,
Cyclophosphamide ,
Methotrexate sodium ,
Azathioprine sodium ,
Cyclophosphamide 💬 		2件: DHFR,
DHFR2 💬 		3件: Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬1件: 44 💬
1842Cyclophosphamide Injection 1g1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--3件: 50, 51, 52 💬
1843Cyclophosphamide LD1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--1件: 49 💬
1844CYCLOPHOSPHAMIDE MONOHYDRATE1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--4件: 13, 60, 96, 256 💬
1845Cyclophosphamide post transplant1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--1件: 65 💬
1846Cyclophosphamide(CTX)1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--1件: 224 💬
1847Cyclophosphamide, Azathioprine,prednisone,methylprednisolone4件: Azathioprine,
Cyclophosphamide,
Methylprednisolone,
Prednisone		7件: Azathioprine ,
Cyclophosphamide ,
Methylprednisolone ,
Prednisone ,
Methylprednisolone acetate ,
Azathioprine sodium ,
Cyclophosphamide 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬3件: 42, 43, 45 💬
1848Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) regimen3件: Bortezomib,
Cyclophosphamide,
Dexamethasone		6件: Cyclophosphamide ,
Dexamethasone ,
Dexamethasone sodium phosphate ,
Bortezomib ,
Cyclophosphamide ,
Dexamethasone phosphate 💬 		2件: NR3C1,
PSMB5 💬 		9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28 💬
1849Cyclophosphamide, Fludarabine2件: Cyclophosphamide,
Fludarabine		4件: Cyclophosphamide ,
Fludarabine phosphate ,
Cyclophosphamide ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 285 💬
1850Cyclophosphamide, fludarabine , thymoglobulin2件: Cyclophosphamide,
Fludarabine		4件: Cyclophosphamide ,
Fludarabine phosphate ,
Cyclophosphamide ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 60 💬
1851Cyclophosphamide, Fludarabine, Rabbit ATG3件: Cyclophosphamide,
Fludarabine,
Rabbit		4件: Cyclophosphamide ,
Fludarabine phosphate ,
Cyclophosphamide ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 60 💬
1852Cyclophosphamide, Fludarabine, Thymoglobulin2件: Cyclophosphamide,
Fludarabine		4件: Cyclophosphamide ,
Fludarabine phosphate ,
Cyclophosphamide ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 60 💬
1853Cyclophosphamide,Campath IH and TBI1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--1件: 60 💬
1854Cyclophosphamide,cyclosporine A2件: Cyclophosphamide,
Cyclosporine		3件: Cyclosporine ,
Cyclophosphamide ,
Cyclophosphamide 💬 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 60 💬
1855Cyclophosphamide-prednisone-azathioprine3件: Azathioprine,
Cyclophosphamide,
Prednisone		5件: Azathioprine ,
Cyclophosphamide ,
Prednisone ,
Azathioprine sodium ,
Cyclophosphamide 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 49 💬
1856Cyclophosphamide/ATG1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--1件: 13 💬
1857Cyclophosphamide/azathioprine2件: Azathioprine,
Cyclophosphamide		4件: Azathioprine ,
Cyclophosphamide ,
Azathioprine sodium ,
Cyclophosphamide 💬 		--1件: 44 💬
1858Cyclophosphamide/Glatiramer acetate3件: Acetate,
Cyclophosphamide,
Glatiramer		3件: Cyclophosphamide ,
Glatiramer acetate ,
Cyclophosphamide 💬 		20件: HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
1859Cyclophosphamide/Rituximab2件: Cyclophosphamide,
Rituximab		3件: Cyclophosphamide ,
Rituximab ,
Cyclophosphamide 💬 		1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
1860Cyclophosphamidum 500 mg1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--1件: 44 💬
1861Cycloserine1件: Cycloserine1件: Cycloserine 💬 --1件: 2 💬
1862Cyclosphamine----1件: 85 💬
1863Cyclosporin----6件: 53, 60, 97, 222, 223, 274 💬
1864Cyclosporin (CSA)----1件: 60 💬
1865Cyclosporin A----12件: 46, 49, 53, 54, 56, 60, 63, 93, 95, 113, 164, 222 💬
1866Cyclosporin A (CsA)----1件: 60 💬
1867Cyclosporin A+Glucocorticoids----2件: 60, 62 💬
1868Cyclosporin Capsules----1件: 222 💬
1869Cyclosporin, low dose steroid----2件: 222, 223 💬
1870Cyclosporin, Methotrexate (GVHD prophylaxis)1件: Methotrexate2件: Methotrexate ,
Methotrexate sodium 💬 		2件: DHFR,
DHFR2 💬 		3件: Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬1件: 326 💬
1871Cyclosporine1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬39件: 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
1872Cyclosporine (Ciclosporinium)1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
1873Cyclosporine (CsA)1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 60 💬
1874Cyclosporine (Gengraf )1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 60 💬
1875Cyclosporine (USAN)1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 97 💬
1876Cyclosporine + BCX73531件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 65 💬
1877Cyclosporine 0.09% Ophthalmic Solution1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 53 💬
1878Cyclosporine A1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬12件: 19, 20, 36, 49, 50, 53, 58, 60, 107, 228, 234, 283 💬
1879Cyclosporine A (CsA)1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬2件: 19, 60 💬
1880Cyclosporine A dry powder inhalation (Drug)1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
1881Cyclosporine Capsule1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
1882Cyclosporine combine with mycophenolate mofetil2件: Cyclosporine,
Mycophenolate mofetil		3件: Cyclosporine ,
Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride 💬 		7件: IMPDH1,
IMPDH2,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		35件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 283 💬
1883Cyclosporine Inhalation Solution1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
1884Cyclosporine Inhalation Solution (CIS)1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
1885Cyclosporine Injection (IV)1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 97 💬
1886Cyclosporine Oral Product1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬2件: 60, 97 💬
1887Cyclosporine Pill1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 56 💬
1888Cyclosporine Soft Capsules1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 67 💬
1889CYCLOSPORINE VS INFLIXIMAB2件: Cyclosporine,
Infliximab		2件: Cyclosporine ,
Infliximab 💬 		6件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2,
TNF 💬 		85件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amphetamine addiction, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Dopaminergic synapse, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Glucagon signaling pathway, Glutamatergic synapse, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Renin secretion, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Wnt signaling pathway, Yersinia infection, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 97 💬
1890Cyclosporine-A1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 95 💬
1891Cyclosporins----4件: 53, 60, 65, 222 💬
1892CyCol----1件: 97 💬
1893CyCol™----1件: 97 💬
1894CYKLOKAPRON----1件: 65 💬
1895Cyklokapron Tablets----1件: 65 💬
1896Cyklokapron®----1件: 46 💬
1897Cyklosporin A----1件: 54 💬
1898Cyltezo----1件: 96 💬
1899CYMBALTA----3件: 6, 13, 49 💬
1900CYP substrates----1件: 98 💬
1901CYR-064----1件: 6 💬
1902Cystadane anhydrous----1件: 19 💬
1903CYSTADROPS----1件: 19 💬
1904CYSTADROPS 0.55% eye drops, solution----1件: 19 💬
1905CYSTAGON----3件: 8, 19, 299 💬
1906Cystagon (cysteamine bitartrate) immediate-release capsules1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--1件: 299 💬
1907Cystagon 150mg----1件: 19 💬
1908Cystagon 50mg----1件: 19 💬
1909Cystagon®----1件: 19 💬
1910Cystagon® (Cysteamine Bitartrate)1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--1件: 19 💬
1911Cysteamine1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--4件: 8, 19, 21, 299 💬
1912Cysteamine (mercaptamine) viscous solution1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--1件: 19 💬
1913Cysteamine Bitartrate1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--4件: 8, 19, 21, 299 💬
1914Cysteamine bitartrate (Cystagon)1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--1件: 299 💬
1915Cysteamine bitartrate (INN: mercaptamine bitartrate1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--1件: 19 💬
1916Cysteamine bitartrate (INN: mercaptamine bitartrate )1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--1件: 19 💬
1917Cysteamine bitartrate (INN: mercaptamine bitartrate)1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--1件: 19 💬
1918Cysteamine Bitartrate Delayed-release Capsules1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--1件: 19 💬
1919Cysteamine Bitartrate Delayed-release Capsules (RP103)1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--1件: 19 💬
1920CYSTEAMINE HYDROCHLORIDE1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--1件: 19 💬
1921Cysteine1件: Cysteine2件: L-Cysteine ,
Cysteine hydrochloride 💬 		--13件: 6, 13, 19, 34, 60, 84, 85, 88, 90, 254, 296, 310, 337 💬
1922Cysteine hydrochloride1件: Cysteine2件: L-Cysteine ,
Cysteine hydrochloride 💬 		--1件: 254 💬
1923Cystic Fibrosis Ready to Use Supplemental Food----1件: 299 💬
1924Cystic fibrosis transmembrane conductance regulator1件: Cystic fibrosis transmembrane conductance regulator---1件: 299 💬
1925Cystoscopic injection of Botox into the urinary bladder----1件: 6 💬
1926Cystoscopy----1件: 226 💬
1927CYT107----1件: 25 💬
1928Cytarabine1件: Cytarabine2件: Cytarabine ,
Cytarabine hydrochloride 💬 		--8件: 11, 13, 14, 25, 34, 49, 60, 65 💬
1929Cytochrome P450 (CYP) Substrates----2件: 96, 97 💬
1930Cytokine essays----2件: 61, 63 💬
1931Cytokine-treated Veto Cells----1件: 60 💬
1932Cytolytic CD4+ T cells----1件: 13 💬
1933Cytoreductive regimen followed by a CD34+E- selected allogeneic stem cell transplant----1件: 62 💬
1934Cytotoxic Combination----1件: 56 💬
1935Cytoxan----2件: 60, 96 💬
1936CZP----1件: 46 💬
1937Cápsulas de Laquinimod 0.6 mg1件: Laquinimod1件: Laquinimod sodium 💬 --1件: 13 💬
1938Células madre mesenquimales----1件: 13 💬
1939Células madre mesenquimales de tejido adiposo autólogo----1件: 2 💬
1940Células madre mesenquimales haploidénticas derivadas de médula ósea----1件: 36 💬
1941Células Mesenquimales de tejido adiposo----1件: 2 💬
1942Células mesenquimales troncales adultas alogénicas de médula ósea no expandidas----1件: 274 💬
1943Células mesenquimales troncales adultas alogénicas de médula ósea no expandidas(ref cruzada PEI nº 12-088)----1件: 274 💬
1944Células mesenquimales troncales adultas autólogas de medula ósea expandidas----1件: 117 💬
1945Células mesenquimales troncales adultas autólogas de médula ósea expandidas----1件: 117 💬
1946Células Mononucleares troncales adultas autólogas de médula ósea no expandidas----1件: 57 💬
1947Células troncales hematopoyéticas autólogas adultas extraidas de médula ósea----1件: 2 💬
1948Células troncales mesenquimales autólogas derivadas de tejido adiposo expandidas (ASC)----1件: 97 💬